Yitao WANG  王一濤


Chair Professor
Director, Institute of Chinese Medical Sciences
Director, State Key Laboratory of Quality Research in Chinese Medicine (University of Macau)
Co-Chair & General Secretary, Chinese Joint Research Centre for Drug Discovery and Development (Peking University, National Taiwan University, University of Hong Kong and University of Macau)

Academic Qualifications | Teaching | Research | Selected Publications | Academic Service | Contact Details


Academic Qualifications

  • Postgraduate, Chongqing Medical University
  • BSc, Chengdu University of Chinese Medicine

Teaching

  1. Introduction to Research in Chinese Medicinal Science (MCMC103)
  2. Introduction to Research in Medical Administration (MCMC110)

Research

Research Interests

  • Systematic quality evaluation of Chinese Medicine
  • Drug discovery and development
  • Medicinal administration

Prof Yitao Wang is the founding Director of the Institute of Chinese Medical Sciences (ICMS) at the University of Macau (UM) and of the State Key Laboratory of Quality Research in Chinese Medicine (UM). He is known internationally for his pioneering contributions to the modernisation of Chinese medicine (CM), with an emphasis on systematic evaluation and quality control of CM. He has a long-standing interest in integrating CM research with the cutting-edge areas of systems pharmacology and molecular pharmaceutics. In the past 10 years, he has published 200+ research papers in international peer-reviewed journals included in Science Citation Index (SCI) with a notable h-index of 31, authored 230+ papers in Chinese, (co-)edited 16 academic books, and supervised 100 PhD/MSc graduates and 20 postdoctoral researchers.

Prof Wang obtained his Bachelor degree (Medical Sciences, 1982) from Chengdu University of Chinese Medicine (CUCM), and completed his postgraduate study (Pharmacology, 1986) at Chongqing Medical University. After a research stint as Visiting Scholar at Hiroshima University in Japan, he returned to CUCM in 1989 where he contributed to mark several firsts in the history of CM – by establishing the first state key subject in CM education, the first Bachelor programme in Pharmacology of CM, the first postdoctoral training programme in CM, as well as the first “National training base for talents in science – CM”. He served in turn as Dean and Vice President of CUCM, and moved in 1996 to Beijing to take the post of Vice President and Director of Chinese Academy of Chinese Medical Sciences, where he became in 1999 the Chief Scientist for China’s first National Basic Research Program of China (973 Program) in the field of CM. In 2000, Prof Wang was appointed Professor and Director for the CM Programme at the Hong Kong University of Science and Technology (HKUST).

In 2002, Yitao set off for Macau and founded the ICMS at UM, which has in 10 years evolved to be a promising academic hub to provide complete programmes from BSc, MSc, PhD to postdoctoral training in Biomedical Sciences. In 2008, together with other local experts, he drafted the proposal to launch the first state key laboratory in CM. This application was approved in 2010 by the Ministry of Science and Technology of China, which announced to establish in Macao the State Key Laboratry of Quality Research in Chinese Medicine, as China’s first state key laboratory in CM. In 2012, he initiated the creation of the Chinese Joint Research Centre for Drug Discovery and Development among Peking University, National Taiwan University, University of Hong Kong and UM, a strategic partnership to mark the first substantial collaboration in science and technonlogy among the four most elite universities in the Greater China region. In line with these accomplishments, Yitao has also initiated joint training programmes and academic collaborations with world-renown universities (e.g. Harvard University, Yale University, University of Chicago and Cambridge University) and organisations (like the World Health Organisation and the US Pharmacopeial Convention).

Prof Wang has been awarded over 30 major funding grants from national, provincial, and special administrative regional administrations. These supports include the prestigious National Basic Research Programme (973), Mega-projects of Scientific Research for 10th Five-Year Plan, China Ministry of Education Key Project, Macao S&T Development Fund, among others. His outstanding achievements in academic service have been recognised by 11 prestigious awards, including the Special Allowance for Experts with Outstanding Contribution from the National Council (1993), National Science and Technology Progress Award (1998), National Intellectual Property Outstanding Achievement Award (1998), Macau Medal of Merit – Education (2011), 1st Macao Science and Technology Awards - Natural Science Award (2012), 2nd Macao Science and Technology Awards - Natural Science Award (2014).Yitao also holds adjunct appointments as Director of International Research Centre of Medicinal Administration at Peking University and as adjunct professors / visiting scholars at numerous universities worldwide, and was elected General Secretory for the International Society for Chinese Medicine and Deputy Secretory for the World Federation of Chinese Medicine Societies. In addition, Yitao serves on several of China’s national committee panels including National Science and Technology Programmes, National Basic Research Programme (973), National Natural Science Foundation, the State Science and Technology Awards and National Centre for Drug Evaluation.

 


Selected Publications

 

Book chapters / Monographs

  1. Advances in Chinese Medicinal Approach to Cancer. Beijing: People’s Medical Publishing House, 2012, ISBN 9787117162272, 7117162279. Chief Editor
  2. Chromatographic Analysis of Commonly Used Chinese Material Medica, Macao: University of Macau Press, 2009, ISBN 978-99937-970-6-7. Co-Chief Editor.
  3. Pharmacological Activity-Based Quality Control of Chinese Herbs, Nova Science Publishers, Inc, 2008, ISBN-10: 1-60456-823-2. Co-Chief Editor.
  4. Chinese Medical Sciences collection Series (A)–Progress in Medicinal Administration Research. Macao: University of Macau Press, 2005, ISBN 99937-26-50-8. Chief Editor.
  5. Chinese Medical Sciences collection Series (B)–Progress in Traditional Chinese Medical Research. Macao: University of Macau Press, 2005, ISBN 99937-26-51-6. Chief Editor.
  6. Chinese Medical Sciences collection Series (C) – Quality Evaluation for Chinese Medicine 1. Macao: University of Macau Press, 2005, ISBN 99937-26-52-4. Chief Editor.
  7. Chinese Medical Sciences collection Series (C) – Quality Evaluation for Chinese Medicine 2. Macao: University of Macau Press, 2005, ISBN 99937-26-53-2. Chief Editor.
  8. Chinese Medical Sciences collection Series (C) – Quality Evaluation for Chinese Medicine 3. Macao: University of Macau Press, 2005, ISBN 99937-26-54-0. Chief Editor.
  9. Chinese Medical Sciences collection Series (C) – Quality Evaluation for Chinese Medicine 4. Macao: University of Macau Press, 2005, ISBN 99937-26-55-9. Chief Editor.
  10. Chinese Medical Sciences collection Series (C) – Quality Evaluation for Chinese Medicine 5. Macao: University of Macau Press, 2005, ISBN 99937-26-56-7. Chief Editor.
  11. Chinese Medical Sciences collection Series (C) – Quality Evaluation for Chinese Medicine 6. Macao: University of Macau Press, 2005, ISBN 99937-26-57-5. Chief Editor.
  12. Chinese Terms in Chinese Medicine and Pharmacy. Beijing: Science Press, 2005, ISBN 7-03-015154-2, Associate Editor.
  13. Intellectual Property Protection of TCM. Beijing: China Press of TCM, 2003, ISBN 7-80-15641-89, Chief Editor.
  14. Drug Administration of European Union and Traditional Chinese Medicine. China International Culture Press Limited, 1999, Associate Editor.
  15. Tranditional Chinese Medicine pharmacology and application. Beijing: People’s Medical Publishing House, 1997, ISBN 7-117-03057-7/R.3058, Associate Editor.
  16. New product development from Tranditional Chinese Medicine. Beijing: People’s Medical Publishing House, 1997, ISBN 7-117-02640-5, Chief Editor.

International peer-reviewed journals / Science Citation Index-included (* denotes corresponding author)

  1. Zou LD, Chen FQ, Bao JL, Wang SP, Wang L, Chen MW, He CW, Wang YT. Preparation, characterization, and anticancer efficacy of evodiamine-loaded PLGA nanoparticles. Drug Delivery. In press. (IF=2.202)
  2. Zhang JM, Li YB, Gao W, Repka MA, Wang YT*, Chen MW. Andrographolide-loaded PLGA-PEG-PLGA micelles to improve its bioavailability and anticancer efficacy. Expert Opinion on Drug Delivery. In press. (IF=4.116)
  3. Wang L, Li HT, Wang SP, Liu R, Wu ZS, Wang CM, Wang YT, Chen MW. Enhancing the Antitumor Activity of Berberine Hydrochloride by Solid Lipid Nanoparticle Encapsulation. AAPS PharmSciTech. In press. (IF=1.776)
  4. Pratheeshkumar P, Son YO, Wang X, Divya SP, Joseph B, Hitron JA, Wang L, Kim D, Yin Y, Roy RV, Lu J, Zhang Z, Wang YT, Shi X. Cyanidin-3-Glucoside inhibits UVB-induced oxidative damage and inflammation by regulating MAP kinase and NF-kappaB signalling pathways in SKH-1 hairless mice skin. Toxicology and Applied Pharmacology. In press. (IF=3.630)
  5. Li XW, Yang Y, Henry RJ, Rossetto M, Wang YT*, Chen SL. Plant DNA barcoding: From gene to genome. Biological Reviews. In press. (IF=9.790)
  6. Guo JJ, Pan W, Chen MW, Wang CM, Wang YT*. Overview of Taiwan's indigenous ethnopharmacology in the perspective of traditional knowledge protection. Chinese Journal of Integrative Medicine. In press. (IF=1.401)
  7. Chen RE, Wang SP, Zhang JM, Chen MW, Wang YT*. Aloe-emodin loaded solid lipid nanoparticles: formulation design and in vitro anti-cancer study. Drug Delivery. In press. (IF=2.202)
  8. Zhu HL, Wan JB, Wang YT, Li BC, Xiang C, He J, Li P. Medicinal compounds with antiepileptic/anticonvulsant activities. Epilepsia. 2014, 55(1): 3-16. (IF=4.584)
  9. Zhong ZF, Tan W, Chen XP, Wang YT*. Furanodiene, a natural small molecule suppresses metastatic breast cancer cell migration and invasion in vitro. European Journal of Pharmacology. 2014, 737: 1-10. (IF=2.684)
  10. Zhang XJ, Su HX, He CW, Wang YT, Yang FQ, Wan JB. Discrimination of Pterocephalus hookeri collected at flowering and non-flowering stages using GC-MS-based fatty acid profiling. Analytical Methods. 2014, 6(7): 2141-2149. (IF=1.938)
  11. Yuan YF, Song YL, Jing WH, Wang YT, Yang XY, Liu DY. Simultaneous determination of caffeine, gallic acid, theanine, (-)-epigallocatechin and (-)-epigallocatechin-3-gallate in green tea using quantitative H-1-NMR spectroscopy. Analytical Methods. 2014, 6(3): 907-914. (IF=1.938)
  12. Yan ZX, Lin G, Yec Y, Wang YT, Yan R. Triterpenoid saponins profiling by adducts-targeted neutral loss triggered enhanced resolution and product ion scanning using triple quadrupole linear ion trap mass spectrometry. Analytica Chimica Acta. 2014, 819: 56-64. (IF=4.517)
  13. Yan ZX, Lin G, Ye Y, Wang YT, Yan R. A Generic Multiple Reaction Monitoring Based Approach for Plant Flavonoids Profiling Using a Triple Quadrupole Linear Ion Trap Mass Spectrometry. Journal of the American Society for Mass Spectrometry. 2014, 25(6): 955-965. (IF=3.193)
  14. Xu WS, Li T, Wu GS, Dang YY, Hao WH, Chen XP, Lu JJ, Wang YT*. Effects of Furanodiene on 95-D Lung Cancer Cells: Apoptosis, Autophagy and G1 Phase Cell Cycle Arrest. American Journal of Chinese Medicine. 2014, 42(1): 243-255. (IF=2.625)
  15. Xu WS, Dang YY, Chen XP, Lu JJ, Wang YT*. Furanodiene Presents Synergistic Anti-proliferative Activity With Paclitaxel Via Altering Cell Cycle and Integrin Signaling in 95-D Lung Cancer Cells. Phytotherapy Research. 2014, 28(2): 296-299. (IF=2.397)
  16. Xu JC, Kong XJ, Qiu L, Geng XM, Hu YJ, Wang YT*. Research and development of anti-Alzheimer's drugs: an analysis based on technology flows measured by patent citations. Expert Opinion on Therapeutic Patents. 2014, 24(7): 791-800. (IF=3.441)
  17. Xiang C, Li F, Zhang LD, Li BC, He J, Qin Y, Wan JB, Wang YT, Li P. Determination of radical scavengers from Salvia plants by HPLC. Analytical Letters. 2014, 47(1): 1-13. (IF=0.982)
  18. Wu WJ, Yan R, Yao MC, Zhan Y, Wang YT. Pharmacokinetics of anthraquinones in rat plasma after oral administration of a rhubarb extract. Biomedical Chromatography. 2014, 28(4): 564-572. (IF=1.662)
  19. Wu WJ, Hu N, Zhang QW, Li YP, Li P, Yan R, Wang YT. In vitro glucuronidation of five rhubarb anthraquinones by intestinal and liver microsomes from humans and rats. Chemico-Biological Interactions. 2014, 219: 18-27. (IF=2.982)
  20. Wang SP, Wang L, Shi Z, Zhong ZF, Chen MW, Wang YT*. Evodiamine Synergizes with Doxorubicin in the Treatment of Chemoresistant Human Breast Cancer without Inhibiting P-Glycoprotein. Plos One. 2014, 9(5): e97512. (IF=3.534)
  21. Wang L, Wang SP, Chen RE, Wang YP, Li H, Wang YT, Chen MW. Oridonin Loaded Solid Lipid Nanoparticles Enhanced Antitumor Activity in MCF-7 Cells. Journal of Nanomaterials. 2014: 903646. (IF=1.611)
  22. Tang ZH, Li T, Gao HW, Sun W, Chen XP, Wang YT, Lu JJ. Platycodin D from Platycodonis Radix enhances the anti-proliferative effects of doxorubicin on breast cancer MCF-7 and MDA-MB-231 cells. Chinese Medicine. 2014, 9: 16. (IF=2.343)
  23. Song YL, Yan HX, Chen JF, Wang YT, Jiang Y, Tu PF. Characterization of in vitro and in vivo metabolites of carnosic acid, a natural antioxidant, by high performance liquid chromatography coupled with tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis. 2014, 89: 183-196. (IF=2.829)
  24. Song YL, Jing WH, Yang FQ, Shi Z, Yao MC, Yan R, Wang YT*. Simultaneously enantiospecific determination of (+)-trans-khellactone, (+/-)-praeruptorin A, (+/-)-praeruptorin B, (+)-praeruptorin E, and their metabolites, (+/-)-cis-khellactone, in rat plasma using online solid phase extraction-chiral LC-MS/MS. Journal of Pharmaceutical and Biomedical Analysis. 2014, 88: 269-277. (IF=2.829)
  25. Song YL, Jing WH, Yan R, Wang YT*. Metabolic characterization of (+/-)-praeruptorin A in vitro and in vivo by high performance liquid chromatography coupled with hybrid triple quadrupole-linear ion trap mass spectrometry and time-of-flight mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis. 2014, 90: 98-110. (IF=2.829)
  26. Song YL, Jing WH, Yan R, Wang YT*. A pretreatment free method for the determination of seven natural products in a high-salt matrix by online guard column extraction coupled with tandem mass spectrometry. Analytical Methods. 2014, 6(2): 623-628. (IF=1.938)
  27. Song YL, Jing WH, Tu PF, Wang YT*. Development of enantiospecific and chemoselective methods for the determination of praeruptorin A enantiomers and their metabolites in rat plasma using chiral and achiral LC-MS/MS. Analytical Methods. 2014, 6(13): 4831-4839. (IF=1.938)
  28. Song YL, Jing WH, Tu PF, Wang YT*. Enantiomeric separation of angular-type pyranocoumarins from Peucedani Radix using AD-RH chiral column. Natural Product Research. 2014, 28(8): 545-550. (IF=1.225)
  29. Song YL, Jing WH, Du G, Yang FQ, Yan R, Wang YT*. Qualitative analysis and enantiospecific determination of angular-type pyranocoumarins in Peucedani Radix using achiral and chiral liquid chromatography coupled with tandem mass spectrometry. Journal of Chromatography A. 2014, 1338: 24-37. (IF=4.258)
  30. Song YL, Jing WH, Chen YG, Yuan YF, Yan R, Wang YT*. 1H nuclear magnetic resonance based-metabolomic characterization of Peucedani Radix and simultaneous determination of praeruptorin A and praeruptorin B. Journal of Pharmaceutical and Biomedical Analysis. 2014, 93: 86-94. (IF=2.829)
  31. Song YL, Jing WH, Tu PF, Wang YT*. Characterization of Peucedani Radix extract-derived angular-type pyranocoumarins in rats using ultra-high performance liquid chromatography coupled with hybrid triple quadrupole-linear ion trap mass spectrometry. Analytical Methods. 2014, 6(14): 5198-5206. (IF=1.938)
  32. Song J, Wang YC, Song YL, Chan H, Bi C, Yang X, Yan R, Wang YT, Zheng Y. Development and Characterisation of Ursolic Acid Nanocrystals Without Stabiliser Having Improved Dissolution Rate and In Vitro Anticancer Activity. AAPS Pharmscitech. 2014, 15(1): 11-19. (IF=1.776)
  33. Shen DY, Wei JC, Wan JB, Huang XJ, Xiang C, Li BC, Zhang QW, Wang YT, Li P. Four new C21 steroidal glycosides from Cynanchum otophyllum Schneid. Phytochemistry Letters. 2014, 9(1): 86-91. (IF=1.542)
  34. Qiu L, Chen ZY, Lu DY, Hu H, Wang YT*. Public funding and private investment for R&D: a survey in China's pharmaceutical industry. Health Research Policy and Systems. 2014, 12: 27. (IF=1.860)
  35. Niu YM, Bai J, Kamm RD, Wang YT, Wang CM. Validating antimetastatic effects of natural products in an engineered microfluidic platform mimicking tumor microenvironment. Molecular Pharmaceutics. 2014, 11(7): 2022-2029. (IF=4.787)
  36. Ni JY, Xu JC, Hu YJ, Su L, Wang YT. Cross-regional Pharmaceutical Technology Transfer in China Patterns and Proposed Investment Strategies. Therapeutic Innovation & Regulatory Science. 2014, 48(2): 226-235.
  37. Ma ZQ, Hu H, He TT, Guo H, Zhang MY, Chen MW, Wang YT. An assessment of traditional Uighur medicine in current Xinjiang region (China). African Journal of Traditional Complementary and Alternative Medicines. 2014, 11(2): 301-314. (IF=0.560)
  38. Liu LJ, Leung KH, Chan DSH, Wang YT, Ma DL, Leung CH. Identification of a natural product-like STAT3 dimerization inhibitor by structure-based virtual screening. Cell Death and Disease. 2014, 5(6): e1293. (IF=5.177)
  39. Liu JJ, Wang YT*, Qiu L, Yu YY, Wang CM. Saponins of Panax notoginseng: chemistry, cellular targets and therapeutic opportunities in cardiovascular diseases. Expert Opinion on Investigational Drugs. 2014, 23(4): 523-539. (IF=5.432)
  40. Lin LG, Xie H, Wang YT, Ding J, Ye Y. Chemical Constituents from the Heartwood of Haematoxylon campechianum as Protein Tyrosine Kinase Inhibitors. Chemistry & Biodiversity. 2014, 11(5): 776-783. (IF=1.795)
  41. Li T, Xu WS, Wu GS, Chen XP, Wang YT*, Lu JJ. Platycodin D Induces Apoptosis, and Inhibits Adhesion, Migration and Invasion in HepG2 Hepatocellular Carcinoma Cells. Asian Pacific Journal of Cancer Prevention. 2014, 15(4): 1745-1749. (IF=1.500)
  42. Hu N, Mei M, Ruan JQ, Wu WJ, Wang YT, Yan R. Regioselective Glucuronidation of Oxyresveratrol, a Natural Hydroxystilbene, by Human Liver and Intestinal Microsomes and Recombinant UGTs. Drug Metabolism and Pharmacokinetics. 2014, 29(3): 229-236. (IF=2.863)
  43. Chen YG, Song YL, Wang Y, Yuan YF, Huang XJ, Ye WC, Wang YT, Zhang QW. Metabolic differentiations of Pueraria lobata and Pueraria thomsonii using H-1 NMR spectroscopy and multivariate statistical analysis. Journal of Pharmaceutical and Biomedical Analysis. 2014, 93: 51-58. (IF=2.829)
  44. Chen XP, Guo JJ, Bao JL, Lu JJ, Wang YT. The Anticancer Properties of Salvia Miltiorrhiza Bunge (Danshen): A Systematic Review. Medicinal Research Reviews. 2014, 34(4): 768-794. (IF=8.131)
  45. Chen RE, Zhang JM, Hu YY, Wang SP, Chen MW, Wang YT*. Potential Antineoplastic Effects of Aloe-emodin: A Comprehensive Review. American Journal of Chinese Medicine. 2014, 42(2): 275-288. (IF=2.625)
  46. Qiu L, Yu YY, Liu JJ, Hu H, Wang YT. For-profit medical institutions in China: Current status analysis and comparison with non-profit ones. Journal of Pharmaceutical Health Services Research. 2014, 5(1): 37-47.
  47. Chen MW, Chen WR, Zhang JM, Long XY, Wang YT*. Lobelia chinensis: chemical constituents and anticancer activity perspective. Chinese Journal of Natural Medicines. 2014, 12(2): 103-107.
  48. Ding RB, Bao JL, Cao YW, He CW, Wang YT, Wan JB. Panax notoginseng saponins protect against chronic ethanol-induced hepatic steatosis. Journal of Chinese Pharmaceutical Sciences. 2014, 23(6): 361-368.
  49. Zhao HY, Hu H, Wang YT. Comparative metabolism and stability of andrographolide in liver microsomes from humans, dogs and rats using ultra-performance liquid chromatography coupled with triple-quadrupole and Fourier transform ion cyclotron resonance mass spectrometry. Rapid Communications in Mass Spectrometry. 2013, 27(12): 1385-1392. (IF=2.642)
  50. Zhang XJ, Huang LL, Cai XJ, Li P, Wang YT*, Wan JB. Fatty acid variability in three medicinal herbs of Panax species. Chemistry Central Journal. 2013, 7: 12. (IF=1.663)
  51. Yao XL, Ye CH, Liu Q, Wan JB, Zhen J, Xiang AP, Li WQ, Wang YT, Su HX, Lu XL. Motoneuron Differentiation of Induced Pluripotent Stem Cells from SOD1G93A Mice. Plos One. 2013, 8(5): e64720. (IF=3.534)
  52. Xu ZT, Wu GS, Wei X, Chen XP, Wang YT*, Chen LD. Celastrol Induced DNA Damage, Cell Cycle Arrest, and Apoptosis in Human Rheumatoid Fibroblast-Like Synovial Cells. American Journal of Chinese Medicine. 2013, 41(3): 615-628. (IF=2.625)
  53. Wu GS, Song YL, Yin ZQ, Guo JJ, Wang SP, Zhao WW, Chen XP, Zhang QW, Lu JJ, Wang YT*. Ganoderiol A-Enriched Extract Suppresses Migration and Adhesion of MDA-MB-231 Cells by Inhibiting FAK-SRC-Paxillin Cascade Pathway. Plos One. 2013, 8(10): e76620. (IF=3.534)
  54. Wu GS, Lu JJ, Guo JJ, Huang MQ, Gan L, Chen XP, Wang YT*. Synergistic anti-cancer activity of the combination of dihydroartemisinin and doxorubicin in breast cancer cells. Pharmacological Reports. 2013, 65(2): 453-459. (IF=2.165)
  55. Wu GS, Guo JJ, Bao JL, Li XW, Chen XP, Lu JJ, Wang YT*. Anti-cancer properties of triterpenoids isolated from Ganoderma lucidum - a review. Expert Opinion on Investigational Drugs. 2013, 22(8): 981-992. (IF=5.432)
  56. Wang SP, Zhong ZF, Wan JB, Tan W, Wu GS, Chen MW, Wang YT*. Oridonin Induces Apoptosis, Inhibits Migration and Invasion on Highly-Metastatic Human Breast Cancer Cells. American Journal of Chinese Medicine. 2013, 41(1): 177-196. (IF=2.625)
  57. Wang SP, Zhang JM, Chen MW, Wang YT*. Delivering flavonoids into solid tumors using nanotechnologies. Expert Opinion on Drug Delivery. 2013, 10(10): 1411-1428. (IF=4.116)
  58. Wang L, Zhang JM, Hong YL, Feng Y, Chen MW, Wang YT. Phytochemical and Pharmacological Review of Da Chuanxiong Formula: A Famous Herb Pair Composed of Chuanxiong Rhizoma and Gastrodiae Rhizoma for Headache. Evidence-Based Complementary and Alternative Medicine. 2013: 425369. (IF=2.175)
  59. Wan JB, Li P, Yang RL, Zhang QW, Wang YT. Separation and purification of 5 saponins from Panax notoginseng by preparative high-performance liquid chromatography. Journal of Liquid Chromatography & Related Technologies. 2013, 36(3): 406-417. (IF=0.638)
  60. Wan JB, Bai X, Cai XJ, Rao Y, Wang YS, Wang YT*. Chemical differentiation of Da-Cheng-Qi-Tang, a Chinese medicine formula, prepared by traditional and modern decoction methods using UPLC/Q-TOFMS-based metabolomics approach. Journal of Pharmaceutical and Biomedical Analysis. 2013, 83: 34-42. (IF=2.829)
  61. Su HX, Wang LH, Huang WH, Qin DJ, Cai JL, Yao XL, Feng CQ, Li ZY, Wang YT, So KF, Pan GJ, Wu WT, Pei DQ. Immediate expression of Cdh2 is essential for efficient neural differentiation of mouse induced pluripotent stem cells. Stem Cell Research. 2013, 10(3): 338-348. (IF=3.912)
  62. Su HX, Wang LH, Cai JL, Yuan QJ, Yang XY, Yao XL, Wong WM, Huang WH, Li ZY, Wan JB, Wang YT, Pei DQ, So KF, Qin DJ, Wu WT. Transplanted motoneurons derived from human induced pluripotent stem cells form functional connections with target muscle. Stem Cell Research. 2013, 11(1): 529-539. (IF=3.912)
  63. Shen H, Leung WI, Ruan JQ, Li SL, Lei JPC, Wang YT, Yan R. Biotransformation of ginsenoside Rb1 via the gypenoside pathway by human gut bacteria. Chinese Medicine. 2013, 8: 22. (IF=2.343)
  64. Lu JJ, Bao JL, Wu GS, Xu WS, Huang MQ, Chen XP, Wang YT*. Quinones Derived from Plant Secondary Metabolites as Anti-cancer Agents. Anti-Cancer Agents in Medicinal Chemistry. 2013, 13(3): 456-463. (IF=2.939)
  65. Li YB, Zhong ZF, Chen MW, Bao JL, Wu GS, Zhang QW, Lee SMY, Hoi PM, Wang YT*. Bisdemethoxycurcumin Increases Sirt1 to Antagonize t-BHP-Induced Premature Senescence in WI38 Fibroblast Cells. Evidence-Based Complementary and Alternative Medicine. 2013: 851714. (IF=2.175)
  66. Li YB, Wang ZQ, Yan X, Chen MW, Bao JL, Wu GS, Ge ZM, Zhou DM, Wang YT*, Li RT. IC-4, a new irreversible EGFR inhibitor, exhibits prominent anti-tumor and anti-angiogenesis activities. Cancer Letters. 2013, 340(1): 88-96. (IF=5.016)
  67. Li YB, Gao JL, Zhong ZF, Hoi PM, Lee SMY, Wang YT*. Bisdemethoxycurcumin suppresses MCF-7 cells proliferation by inducing ROS accumulation and modulating senescence-related pathways. Pharmacological Reports. 2013, 65(3): 700-709. (IF=2.165)
  68. Jing WH, Song YL, Yan R, Wang YT. Identification of cytochrome P450 isoenzymes involved in metabolism of (+)-praeruptorin A, a calcium channel blocker, by human liver microsomes using ultra high-performance liquid chromatography coupled with tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis. 2013, 77: 175-188. (IF=2.829)
  69. Huang L, Wu Q, Li YH, Wang YT, Bi HC. PXR-Mediated Upregulation of CYP3A Expression by Herb Compound Praeruptorin C from Peucedanum praeruptorum Dunn. Evidence-Based Complementary and Alternative Medicine. 2013: 156574. (IF=2.175)
  70. Huang L, Huang M, Li YH, Li RM, Zeng Y, Kuang SY, Zhang L, Wang YT, Bi HC. Up-regulatation of CYP3A expression through pregnent X receptor by praeruptorin D isolated from Peucedanum praeruptorum Dunn. Journal of Ethnopharmacology. 2013, 148(2): 596-602. (IF=2.939)
  71. Huang L, Bi HC, Li YH, Zhang JQ, Kuang SY, Zhang L, Wang YT, Huang M. Regulation of Human Pregnane X Receptor and its Target Gene Cytochrome P450 3A by Praeruptorin A Isolated from the Herbal Medicine Peucedanum praeruptorum. Planta Medica. 2013, 79(16): 1509-1515. (IF=2.339)
  72. Hu YY, Wang SP, Wu X, Zhang JM, Chen R, Chen MW, Wang YT*. Chinese herbal medicine-derived compounds for cancer therapy: A focus on hepatocellular carcinoma. Journal of Ethnopharmacology. 2013, 149(3): 601-612. (IF=2.939)
  73. Hu YJ, Scherngell T, Man SN, Wang YT*. Is the United States Still Dominant in the Global Pharmaceutical Innovation Network? Plos One. 2013, 8(11): e77247. (IF=3.534)
  74. Han W, Wang SP, Liang RX, Wang L, Chen MW, Li H, Wang YT. Non-ionic surfactant vesicles simultaneously enhance antitumor activity and reduce the toxicity of cantharidin. International Journal of Nanomedicine. 2013, 8: 2187-2196. (IF=4.195)
  75. Guo Y, Hu YJ, Zheng ML, Wang YT. Patent indicators: a window to pharmaceutical market success. Expert Opinion on Therapeutic Patents. 2013, 23(7): 765-771. (IF=3.441)
  76. Gao L, Fang JS, Bai XY, Zhou D, Wang YT, Liu AL, Du GH. In silico Target Fishing for the Potential Targets and Molecular Mechanisms of Baicalein as an Antiparkinsonian Agent: Discovery of the Protective Effects on NMDA Receptor-Mediated Neurotoxicity. Chemical Biology & Drug Design. 2013, 81(6): 675-687. (IF=2.507)
  77. Chen XP, Lu JJ, Bao JL, Guo JJ, Shi JS, Wang YT*. Adiponectin: A biomarker for rheumatoid arthritis? Cytokine & Growth Factor Reviews. 2013, 24(1): 83-89. (IF=6.537)
  78. Chen MW, Zhang JM, Lai YF, Wang SP, Li P, Xiao J, Fu CM, Hu H, Wang YT*. Analysis of Pogostemon cablin from pharmaceutical research to market performances. Expert Opinion on Investigational Drugs. 2013, 22(2): 245-257. (IF=5.432)
  79. Chen MW, Chen RE, Wang SP, Tan W, Hu YY, Peng XS, Wang YT*. Chemical components, pharmacological properties, and nanoparticulate delivery systems of Brucea javanica. International Journal of Nanomedicine. 2013, 8: 85-92. (IF=4.195)
  80. Yu WP, Yu XW, Hu H, Duan GM, Liu Z, Wang YT. Use of hospital appointment registration systems in China: a survey study. Global journal of health science. 2013, 5(5): 193-201.
  81. Shi HH, Chen MW, Shi YZ, Hu H, Wang YT. Challenges and prospects for monoclonal antibodies in China. Journal of Commercial Biotechnology. 2013, 19(2): 49-55.
  82. Zhou RN, Song YL, Ruan JQ, Wang YT, Yan R. Pharmacokinetic Evidence on the Contribution of Intestinal Bacterial Conversion to Beneficial Effects of Astragaloside IV, a Marker Compound of Astragali Radix, in Traditional Oral Use of the Herb. Drug Metabolism and Pharmacokinetics. 2012, 27(6): 586-597. (IF=2.071)
  83. Zhong ZF, Li YB, Wang SP, Tan W, Chen XP, Chen MW, Wang YT*. Furanodiene enhances tamoxifen-induced growth inhibitory activity of ERa-positive breast cancer cells in a PPAR gamma independent manner. Journal of Cellular Biochemistry. 2012, 113(8): 2643-2651. (IF=3.062)
  84. Zhong ZF, Hoi PM, Wu GS, Xu ZT, Tan W, Chen XP, Cui L, Wu T, Wang YT*. Anti-angiogenic effect of furanodiene on HUVECs in vitro and on zebrafish in vivo. Journal of Ethnopharmacology. 2012, 141(2): 721-727. (IF=2.755)
  85. Zhong ZF, Dang YY, Yuan X, Guo W, Li YB, Tan W, Cui JR, Lu JJ, Zhang QW, Chen XP, Wang YT*. Furanodiene, a Natural Product, Inhibits Breast Cancer Growth Both in vitro and in vivo. Cellular Physiology and Biochemistry. 2012, 30(3): 778-790. (IF=3.415)
  86. Zhao BX, Wang Y, Zhang DM, Huang XJ, Bai LL, Yan Y, Chen JM, Lu TB, Wang YT, Zhang QW, Ye WC. Virosaines A and B, Two New Birdcage-Shaped Securinega Alkaloids with an Unprecedented Skeleton from Flueggea virosa. Organic Letters. 2012, 14(12): 3096-3099. (IF=6.142)
  87. Zhang H, Zhang QW, Wang L, Zhang XQ, Ye WC, Wang YT. Two new anthraquinone malonylglucosides from Polygonum cuspidatum. Natural Product Research. 2012, 26(14): 1323-1327. (IF=1.031)
  88. Yi Y, Zhang QW, Li SL, Wang Y, Ye WC, Zhao J, Wang YT. Simultaneous quantification of major flavonoids in "Bawanghua", the edible flower of Hylocereus undatus using pressurised liquid extraction and high performance liquid chromatography. Food Chemistry. 2012, 135(2): 528-533. (IF=3.334)
  89. Yang F, Zhou WL, Liu AL, Qin HL, Lee SMY, Wang YT, Du GH. The Protective Effect of 3-Deoxysappanchalcone on In Vitro Influenza Virus-induced Apoptosis and Inflammation. Planta Medica. 2012, 78(10): 968-973. (IF=2.348)
  90. Xu ZT, Chen XP, Fu S, Bao JL, Dang YY, Huang MQ, Chen LD, Wang YT*. Dehydrocorydaline Inhibits Breast Cancer Cells Proliferation by Inducing Apoptosis in MCF-7 Cells. American Journal of Chinese Medicine. 2012, 40(1): 177-185. (IF=2.281)
  91. Xu WS, Dang YY, Guo JJ, Wu GS, Lu JJ, Chen XP, Wang YT*. Furanodiene Induces Endoplasmic Reticulum Stress and Presents Antiproliferative Activities in Lung Cancer Cells. Evidence-Based Complementary and Alternative Medicine. 2012: 426521. (IF=1.722)
  92. Wu GS, Qian ZM, Guo JJ, Hu DJ, Bao JL, Xie J, Xu WS, Lu JJ, Chen XP, Wang YT*. Ganoderma lucidum Extract Induces G1 Cell Cycle Arrest, and Apoptosis in Human Breast Cancer Cells. American Journal of Chinese Medicine. 2012, 40(3): 631-642. (IF=2.281)
  93. Wu GS, Lu JJ, Guo JJ, Li YB, Tan W, Dang YY, Zhong ZF, Xu ZT, Chen XP, Wang YT*. Ganoderic acid DM, a natural triterpenoid, induces DNA damage, G1 cell cycle arrest and apoptosis in human breast cancer cells. Fitoterapia. 2012, 83(2): 408-414. (IF=2.231)
  94. Wang SP, Wu X, Tan M, Gong J, Tan W, Bian BL, Chen MW, Wang YT*. Fighting fire with fire: Poisonous Chinese herbal medicine for cancer therapy. Journal of Ethnopharmacology. 2012, 140(1): 33-45. (IF=2.755)
  95. Wang SP, Hu YY, Tan W, Wu X, Chen RE, Cao JL, Chen MW, Wang YT*. Compatibility art of traditional Chinese medicine: From the perspective of herb pairs. Journal of Ethnopharmacology. 2012, 143(2): 412-423. (IF=2.755)
  96. Wang SP, Chen TK, Chen RE, Hu YY, Chen MW, Wang YT*. Emodin loaded solid lipid nanoparticles: Preparation, characterization and antitumor activity studies. International Journal of Pharmaceutics. 2012, 430(1-2): 238-246. (IF=3.458)
  97. Wan JB, Zhang QW, Hong SJ, Li P, Li SP, Wang YT*. Chemical Investigation of Saponins in Different Parts of Panax notoginseng by Pressurized Liquid Extraction and Liquid Chromatography-Electrospray Ionization-Tandem Mass Spectrometry. Molecules. 2012, 17(5): 5836-5853. (IF=2.428)
  98. Song YL, Zhang QW, Li YP, Yan R, Wang YT*. Enantioseparation and Absolute Configuration Determination of Angular-Type Pyranocoumarins from Peucedani Radix Using Enzymatic Hydrolysis and Chiral HPLC-MS/MS Analysis. Molecules. 2012, 17(4): 4236-4251. (IF=2.428)
  99. Song YL, Jing WH, Zhao HY, Yan R, Li PT, Wang YT. Stereoselective metabolism of (±)-praeruptorin A, a calcium channel blocker from Peucedani Radix, in pooled liver microsomes of rats and humans. Xenobiotica. 2012, 42(3): 221-237. (IF=1.984)
  100. Mei M, Ruan JQ, Wu WJ, Zhou RN, Lei JPC, Zhao HY, Yan R, Wang YT. In Vitro Pharmacokinetic Characterization of Mulberroside A, the Main Polyhydroxylated Stilbene in Mulberry (Morus alba L.), and Its Bacterial Metabolite Oxyresveratrol in Traditional Oral Use. Journal of Agricultural and Food Chemistry. 2012, 60(9): 2299-2308. (IF=2.906)
  101. Lu JJ, Pan W, Hu YJ, Wang YT*. Multi-Target Drugs: The Trend of Drug Research and Development. Plos One. 2012, 7(6): e40262. (IF=3.730)
  102. Lu JJ, Dang YY, Huang M, Xu WS, Chen XP, Wang YT*. Anti-cancer properties of terpenoids isolated from Rhizoma Curcumae - A review. Journal of Ethnopharmacology. 2012, 143(2): 406-411. (IF=2.755)
  103. Lu JJ, Bao JL, Chen XP, Huang M, Wang YT*. Alkaloids Isolated from Natural Herbs as the Anticancer Agents. Evidence-Based Complementary and Alternative Medicine. 2012: 485042. (IF=1.722)
  104. Li F, Zhang LD, Li BC, Yang J, Yu H, Wan JB, Wang YT, Li P. Screening of free radical scavengers from Erigeron breviscapus using on-line HPLC-ABTS/DPPH based assay and mass spectrometer detection. Free Radical Research. 2012, 46(3): 286-294. (IF=3.279)
  105. Huang MQ, Xie YL, Chen LD, Chu KD, Wu SS, Lu JJ, Chen XP, Wang YT, Lai XP. Antidiabetic Effect of the Total Polyphenolic Acids Fraction from Salvia miltiorrhiza Bunge in Diabetic Rats. Phytotherapy Research. 2012, 26(6): 944-948. (IF=2.068)
  106. Huang M, Lu JJ, Huang MQ, Bao JL, Chen XP, Wang YT*. Terpenoids: natural products for cancer therapy. Expert Opinion on Investigational Drugs. 2012, 21(12): 1801-1818. (IF=4.744)
  107. Gong J, Chen MW, Zheng Y, Wang SP, Wang YT*. Polymeric micelles drug delivery system in oncology. Journal of Controlled Release. 2012, 159(3): 312-323. (IF=7.633)
  108. Du G, Xiao Y, Yang HR, Wang L, Song YL, Wang YT*. Rapid determination of pesticide residues in herbs using selective pressurized liquid extraction and fast gas chromatography coupled with mass spectrometry. Journal of Separation Science. 2012, 35(15): 1922-1932. (IF=2.591)
  109. Ding RB, Tian K, Huang LL, He CW, Jiang Y, Wang YT, Wan JB. Herbal medicines for the prevention of alcoholic liver disease: A review. Journal of Ethnopharmacology. 2012, 144(3): 457-465. (IF=2.755)
  110. Chen XP, Bao JL, Guo JJ, Ding Q, Lu JJ, Huang MQ, Wang YT. Biological activities and potential molecular targets of cucurbitacins: a focus on cancer. Anti-Cancer Drugs. 2012, 23(8): 777-787. (IF=2.232)
  111. Chen XJ, Zhao J, Wang YT, Huang LQ, Li SP. CE and CEC analysis of phytochemicals in herbal medicines. Electrophoresis. 2012, 33(1): 168-179. (IF=3.261)
  112. Chen XJ, Dinh NP, Zhao J, Wang YT, Li SP, Svec F. Effect of ion adsorption on CEC separation of small molecules using hypercrosslinked porous polymer monolithic capillary columns. Journal of Separation Science. 2012, 35(12): 1502-1505. (IF=2.591)
  113. Chen MW, Zhou YF, Huang JJ, Zhu P, Peng XS, Wang YT. Liposome-Based Delivery Systems in Plant Polysaccharides. Journal of Nanomaterials. 2012: 682545. (IF=1.547)
  114. Chen MW, Zhang JM, Yu SQ, Wang SP, Zhang ZJ, Chen JQ, Xiao J, Wang YT*. Anti-Lung-Cancer Activity and Liposome-Based Delivery Systems of beta-Elemene. Evidence-Based Complementary and Alternative Medicine. 2012: 259523. (IF=1.722)
  115. Lai YF, Lu JJ, Chen XP, Hu H, Wang YT*. Analysis of Anti-cancer Traditional Chinese Medicine Injections based on Market Performance. World Science and Technology - Modernization of Traditional Chinese Medicine and Materia Medica. 2012, 14(5): 1958-1962.
  116. Ge S, Cheong KL, Hu H, Wang YT. Provision and usage of medical services by community pharmacy: A comparative study of New York, Macao and Zhuhai (China). Canadian Social Science. 2012, 8(6): 11-17.
  117. Chen XP, Guo JJ, Bao JL, Xu WS, Huang YJ, Wang YT. Screening Neuroprotective Agents Through 4-hydroxynonenal, Ethanol, High Glucose, Homocysteine, Okadaic Acid, Rotenone, and Oxygen-Glucose Deprivation Induced PC12 Injury Models: A Review. Current Psychopharmacology. 2012, 1(1): 103-110.
  118. Zhong ZF, Chen XP, Tan W, Xu ZT, Zhou KY, Wu T, Cui L, Wang YT*. Germacrone inhibits the proliferation of breast cancer cell lines by inducing cell cycle arrest and promoting apoptosis. European Journal of Pharmacology. 2011, 667(1-3): 50-55. (IF=2.516)
  119. Yeh JC, Cindrova-Davies T, Belleri M, Morbidelli L, Miller N, Cho CWC, Chan K, Wang YT, Luo GA, Ziche M, Presta M, Charnock-Jones DS, Fan TP. The natural compound n-butylidenephthalide derived from the volatile oil of Radix Angelica sinensis inhibits angiogenesis in vitro and in vivo. Angiogenesis. 2011, 14(2): 187-197. (IF=6.063)
  120. .979)
  121. Xu ZT, Chen XP, Zhang QW, Chen LDA, Wang YT*. Corydalis yanhusuo WT Wang Extract Inhibits MCF-7 Cell Proliferation by Inducing Cell Cycle G2/M Arrest. American Journal of Chinese Medicine. 2011, 39(3): 579-586. (IF=1.979)
  122. Wang SP, Tan M, Zhong ZF, Chen MW, Wang YT*. Nanotechnologies for Curcumin: An Ancient Puzzler Meets Modern Solutions. Journal of Nanomaterials. 2011: 723178. (IF=1.376)
  123. Tan W, Li YB, Chen MW, Wang YT*. Berberine hydrochloride: anticancer activity and nanoparticulate delivery system. International Journal of Nanomedicine. 2011, 6: 1773-1777. (IF=3.130)
  124. Song YL, Yan R, Jing WH, Zhao HY, Wang YT*. Characterization of metabolism of (+)-praeruptorin B and (+)-praeruptorin E in human and rat liver microsomes by liquid chromatography coupled with ion trap mass spectrometry and time-of-flight mass spectrometry. Rapid Communications in Mass Spectrometry. 2011, 25(6): 719-730. (IF=2.790)
  125. Liu YH, Mo SL, Bi HC, Hu BF, Li CG, Wang YT, Huang L, Huang M, Duan W, Liu JP, Wei MQ, Zhou SF. Regulation of human pregnane X receptor and its target gene cytochrome P450 3A4 by Chinese herbal compounds and a molecular docking study. Xenobiotica. 2011, 41(4): 259-280. (IF=1.791)
  126. Li ZH, Alex D, Siu SO, Chu IK, Renn J, Winkler C, Lou S, Tsui SKW, Zhao HY, Yan WR, Mahady GB, Li GH, Kwan YW, Wang YT, Lee SMY. Combined in vivo imaging and omics approaches reveal metabolism of icaritin and its glycosides in zebrafish larvae. Molecular Biosystems. 2011, 7(7): 2128-2138. (IF=3.534)
  127. Li YB, Lin ZQ, Zhang ZJ, Wang MW, Zhang HA, Zhang Q, Lee SMY, Wang YT*, Hoi PM. Protective, Antioxidative and Antiapoptotic Effects of 2-Methoxy-6-Acetyl-7-Methyljuglone from Polygonum cuspidatum in PC12 Cells. Planta Medica. 2011, 77(4): 354-361. (IF=2.153)
  128. Li YB, Gao JL, Lee SMY, Zhang QW, Hoi PM, Wang YT*. Bisdemethoxycurcumin protects endothelial cells against t-BHP-induced cell damage by regulating the phosphorylation level of ERK1/2 and Akt. International Journal of Molecular Medicine. 2011, 27(2): 205-211. (IF=1.573)
  129. Li GH, Zhang QW, Wang L, Zhang XQ, Ye WC, Wang YT. New Isoflavone C-Glycosides from Pueraria lobata. Helvetica Chimica Acta. 2011, 94(3): 423-428. (IF=1.478)
  130. Jing WH, Song YL, Yan R, Bi HC, Li PT, Wang YT*. Transport and metabolism of (+/-)-praeruptorin A in Caco-2 cell monolayers. Xenobiotica. 2011, 41(1): 71-81. (IF=1.791)
  131. Huang L, Bi HC, Liu YH, Wang YT, Xue XP, Huang M. CAR-mediated Up-regulation of CYP3A4 Expression in LS174T Cells by Chinese Herbal Compounds. Drug Metabolism and Pharmacokinetics. 2011, 26(4): 331-340. (IF=2.321)
  132. He BC, Gao JL, Luo XJ, Luo JY, Shen JK, Wang LY, Zhou QX, Wang YT, Luu HH, Haydon RC, Wang CZ, Du W, Yuan CS, He TC, Zhang BQ. Ginsenoside Rg3 inhibits colorectal tumor growth through the down-regulation of Wnt/beta-catenin signaling. International Journal of Oncology. 2011, 38(2): 437-445. (IF=2.399)
  133. Du G, Zhao HY, Song YL, Zhang QW, Wang YT*. Rapid simultaneous determination of isoflavones in Radix puerariae using high-performance liquid chromatography-triple quadrupole mass spectrometry with novel shell-type column. Journal of Separation Science. 2011, 34(19): 2576-2585. (IF=2.733)
  134. Du G, Song YL, Wang YT*. Rapid simultaneous determination of multiple pesticide residues in traditional Chinese medicines using programmed temperature vaporizer injection-fast gas chromatography coupled with mass spectrometry. Journal of Separation Science. 2011, 34(23): 3372-3382. (IF=2.733)
  135. Deng YH, Alex D, Huang HQ, Wang N, Yu N, Wang YT, Leung GPH, Lee SMY. Inhibition of TNF-α-mediated Endothelial Cell-Monocyte Cell Adhesion and Adhesion Molecules Expression by the Resveratrol Derivative, trans-3,5,4 '-Trimethoxystilbene. Phytotherapy Research. 2011, 25(3): 451-457. (IF=2.086)
  136. Cui W, Cui GZ, Li WM, Zhang ZJ, Hu SQ, Mak SH, Zhang H, Carlier PR, Choi CL, Wang YT, Lee SMY, Han YF. Bis(12)-hupyridone, a novel multifunctional dimer, promotes neuronal differentiation more potently than its monomeric natural analog huperzine A possibly through alpha7 nAChR. Brain Research. 2011, 1401: 10-17. (IF=2.728)
  137. Chen XP, Zhong ZF, Xu ZT, Chen LD, Wang YT*. No protective effect of curcumin on hydrogen peroxide-induced cytotoxicity in HepG2 cells. Pharmacological Reports. 2011, 63(3): 724-732. (IF=2.445)
  138. Chen XP, Xu ZT, Wang YT*. Recent advances in breast cancer metastasis suppressor 1. International Journal of Biological Markers. 2011, 26(1): 1-8. (IF=1.479)
  139. Chen XP, Wang YT*. Adiponectin and breast cancer. Medical Oncology. 2011, 28(4): 1288-1295. (IF=2.140)
  140. Chen XP, Pei LX, Zhong ZF, Guo JJ, Zhang QW, Wang YT*. Anti-tumor potential of ethanol extract of Curcuma phaeocaulis Valeton against breast cancer cells. Phytomedicine. 2011, 18(14): 1238-1243. (IF=3.268)
  141. Chen MW, Wang SP, Tan M, Wang YT*. Applications of Nanoparticles in Herbal Medicine: Zedoary Turmeric Oil and Its Active Compound beta-Elemene. American Journal of Chinese Medicine. 2011, 39(6): 1093-1102. (IF=1.979)
  142. Wang N, Wan JB, Chan SW, Deng YH, Yu N, Zhang QW, Wang YT, Lee SMY. Comparative study on saponin fractions from Panax notoginseng inhibiting inflammation-induced endothelial adhesion molecule expression and monocyte adhesion. Chinese Medicine. 2011, 6: 37.
  143. Tan W, Lu JJ, Huang MQ, Li YB, Chen MW, Wu GS, Gong J, Zhong ZF, Xu ZT, Dang YY, Guo JJ, Chen XP, Wang YT*. Anti-cancer natural products isolated from chinese medicinal herbs. Chinese Medicine. 2011, 6: 27.
  144. Chen MW, Zhong ZF, Tan W, Wang SP, Wang YT*. Recent advances in nanoparticle formulation of oleanolic acid. Chinese Medicine. 2011, 6: 20.
  145. Shi JM, Han WL, Ye WC, Chen XQ, Wang YT, Zhang QW. Phytochemical Investigation of Corydalis yanhusuo. Natural Product Research and Development. 2011, 23(4): 647-651.
  146. Chen MW, Tan W, Wang SP, Zhong ZF, Wang YT*. Advances in the nanoparticle drug delivery systems of silymarin. Journal of Chinese Pharmaceutical Sciences. 2011, 20(5): 442-446.
  147. Wan JB, Zhang QW, Hong SJ, Guan J, Ye WC, Li SP, Lee MYS, Wang YT*. 5,6-Didehydroginsenosides from the Roots of Panax notoginseng. Molecules. 2010, 15(11): 8169-8176. (IF=1.988)
  148. Ruan JQ, Leong WI, Yan R, Wang YT. Characterization of Metabolism and in Vitro Permeability Study of Notoginsenoside R1 from Radix Notoginseng. Journal of Agricultural and Food Chemistry. 2010, 58(9): 5770-5776. (IF=2.816)
  149. Qin XL, Bi HC, Wang XD, Li JL, Wang Y, Xue XP, Chen X, Wang CX, Xu LJ, Wang YT, Huang M. Mechanistic understanding of the different effects of Wuzhi Tablet (Schisandra sphenanthera extract) on the absorption and first-pass intestinal and hepatic metabolism of Tacrolimus (FK506). International Journal of Pharmaceutics. 2010, 389(1-2): 114-121. (IF=3.607)
  150. Liu AL, Yang F, Zhu MA, Zhou D, Lin M, Lee SMY, Wang YT, Du GH. In Vitro Anti-influenza Viral Activities of Stilbenoids from the Lianas of Gnetum pendulum. Planta Medica. 2010, 76(16): 1874-1876. (IF=2.369)
  151. Liang QY, Chow AHL, Wang YT, Tong HHY, Zheng Y. Removal of toxic aristolochic acid components from Aristolochia plants by supercritical fluid extraction. Separation and Purification Technology. 2010, 72(3): 269-274. (IF=2.775)
  152. Hu YM, Wang YT, Sze SCW, Tsang KW, Wong HK, Liu Q, Zhong LD, Tong Y. Identification of the major chemical constituents and their metabolites in rat plasma and various organs after oral administration of effective Erxian Decoction (EXD) fraction by liquid chromatography-mass spectrometry. Biomedical Chromatography. 2010, 24(5): 479-489. (IF=1.545)
  153. Du G, Zhao HY, Zhang QW, Li GH, Yang FQ, Wang Y, Li YC, Wang YT*. A rapid method for simultaneous determination of 14 phenolic compounds in Radix Puerariae using microwave-assisted extraction and ultra high performance liquid chromatography coupled with diode array detection and time-of-flight mass spectrometry. Journal of Chromatography A. 2010, 1217(5): 705-714. (IF=4.194)
  154. Dang YY, Li XC, Zhang QW, Li SP, Wang YT. Preparative isolation and purification of six volatile compounds from essential oil of Curcuma wenyujin using high-performance centrifugal partition chromatography. Journal of Separation Science. 2010, 33(11): 1658-1664. (IF=2.631)
  155. Chen XP, Zhong ZF, Xu ZT, Chen LD, Wang YT*. 2',7'-Dichlorodihydrofluorescein as a fluorescent probe for reactive oxygen species measurement: Forty years of application and controversy. Free Radical Research. 2010, 44(6): 587-604. (IF=2.805)
  156. Chen XJ, Yang FQ, Wang YT, Li SP. CE and CEC of nucleosides and nucleotides in food materials. Electrophoresis. 2010, 31(13): 2092-2105. (IF=3.569)
  157. Zhang HL, Zhang QW, Zhang XQ, Ye WC, Wang YT. Chemical Constituents from the Roots of Morinda officinalis. Chinese Journal of Natural Medicines. 2010, 8(3): 192-195.
  158. Chen XP, Zhao HY, Zhong ZF, Xu ZT, Wang YT*. "Ox-LDL-LOX-1-ROS" Signaling Pathway Involvement in Foam Cell Formation. Chinese Journal of Arteriosclerosis. 2010, 18(7): 577-581.
  159. Zhang Y, Hu G, Lin HC, Hong SJ, Deng YH, Tang JY, Seto SW, Kwan YW, Waye MMY, Wang YT, Lee SMY. Radix Astragali Extract Promotes Angiogenesis involving Vascular Endothelial Growth Factor Receptor-related Phosphatidylinositol 3-Kinase/Akt-dependent Pathway in Human Endothelial Cells. Phytotherapy Research. 2009, 23(9): 1205-1213. (IF=1.746)
  160. Yu H, Li WM, Cheung MC, Zuo Z, Carlier PR, Gu ZM, Chan K, Huang M, Wang YT*, Han YF. Development and validation of an HPLC-DAD method for bis(12)-hupyridone and its application to a pharmacokinetic study. Journal of Pharmaceutical and Biomedical Analysis. 2009, 49(2): 410-414. (IF=2.453)
  161. Xi J, Chang Q, Chan CK, Meng ZY, Wang GN, Sun JB, Wang YT, Tong HHY, Zheng Y. Formulation Development and Bioavailability Evaluation of a Self-Nanoemulsified Drug Delivery System of Oleanolic Acid. AAPS PharmSciTech. 2009, 10(1): 172-182. (IF=1.190)
  162. Wan JB, Lee SMY, Wang JD, Wang N, He CW, Wang YT*, Kang JX. Panax notoginseng Reduces Atherosclerotic Lesions in ApoE-Deficient Mice and Inhibits TNF-alpha-Induced Endothelial Adhesion Molecule Expression and Monocyte Adhesion. Journal of Agricultural and Food Chemistry. 2009, 57(15): 6692-6697. (IF=2.469)
  163. Sun YY, Xun KL, Wang YT, Chen XP. A systematic review of the anticancer properties of berberine, a natural product from Chinese herbs. Anti-Cancer Drugs. 2009, 20(9): 757-769. (IF=2.230)
  164. Sun YY, Xun KL, Wang CG, Zhao HY, Bi HC, Chen XP, Wang YT. Adiponectin, an Unlocking Adipocytokine. Cardiovascular Therapeutics. 2009, 27(1): 59-75. (IF=2.741)
  165. Liu AL, Shu SH, Qin HL, Lee SMY, Wang YT, Du GH. In vitro Anti-Influenza Viral Activities of Constituents from Caesalpinia sappan. Planta Medica. 2009, 75(4): 337-339. (IF=2.037)
  166. Jiang Y, Li SP, Wang YT, Chen XJ, Tu PF. Differentiation of Herba Cistanches by fingerprint with high-performance liquid chromatography-diode array detection-mass spectrometry. Journal of Chromatography A. 2009, 1216(11): 2156-2162. (IF=4.101)
  167. Hong SJ, Wan JB, Zhang Y, Hu G, Lin HC, Seto SW, Kwan YW, Lin ZX, Wang YT, Lee SMY. Angiogenic Effect of Saponin Extract from Panax notoginseng on HUVECs In Vitro and Zebrafish In Vivo. Phytotherapy Research. 2009, 23(5): 677-686. (IF=1.746)
  168. Gao JL, Shi JM, Lee SMY, Zhang QW, Wang YT*. Angiogenic Pathway Inhibition of Corydalis yanhusuo and Berberine in Human Umbilical Vein Endothelial Cells. Oncology Research. 2009, 17(11-12): 519-526. (IF=1.478)
  169. Gao JL, He TC, Li YB, Wang YT*. A traditional Chinese medicine formulation consisting of Rhizoma Corydalis and Rhizoma Curcumae exerts synergistic anti-tumor activity. Oncology Reports. 2009, 22(5): 1077-1083. (IF=1.588)
  170. Chen XP, Xun KL, Chen LD, Wang YT. TNF-α, a potent lipid metabolism regulator. Cell Biochemistry and Function. 2009, 27(7): 407-416. (IF=1.515)
  171. Chen XJ, Zhao J, Meng Q, Li SP, Wang YT*. Simultaneous determination of five flavonoids in licorice using pressurized liquid extraction and capillary electrochromatography coupled with peak suppression diode array detection. Journal of Chromatography A. 2009, 1216(43): 7329-7335. (IF=4.101)
  172. Chen XJ, Tu PF, Jiang Y, Wang YT, Li SP. Effect of stability of internal standard on quantification of 15 flavonoids in Epimedium using CZE. Journal of Separation Science. 2009, 32(2): 275-281. (IF=2.551)
  173. Li GH, Zhang QW, Hang WH, Wang YT. Isoflavone C-glycosides from Pueraria lobata. Asian Chemistry Letters. 2009, 13(1&2): 35-40.
  174. Zhang L, Yu H, Li WM, Cheung MC, Pang YP, Gu ZM, Chan K, Wang YT, Zuo Z, Han YF. Preclinical characterization of intestinal absorption and metabolism of promising anti-Alzheimer's dimer bis(7)-tacrine. International Journal of Pharmaceutics. 2008, 357(1-2): 85-94. (IF=3.061)
  175. Yu H, Li WM, Kan KKW, Ho JMK, Carlier PR, Pang YP, Gu ZM, Zhong Z, Chan K, Wang YT*, Han YF. The physicochemical properties and the in vivo AChE inhibition of two potential anti-Alzheimer agents, bis(12)-hupyridone and bis(7)-tacrine. Journal of Pharmaceutical and Biomedical Analysis. 2008, 46(1): 75-81. (IF=2.629)
  176. Xiao Y, Yang FQ, Li SP, Hu G, Lee SMY, Wang YT. Essential oil of Curcuma wenyujin induces apoptosis in human hepatoma cells. World Journal of Gastroenterology. 2008, 14(27): 4309-4318. (IF=2.081)
  177. Wang J, Huang ZG, Cao H, Wang YT, Hui P, Hoo C, Li SP. Screening of anti-platelet aggregation agents from Panax notoginseng using human platelet extraction and HPLC-DAD-ESI-MS/MS. Journal of Separation Science. 2008, 31(6-7): 1173-1180. (IF=2.746)
  178. Wan JB, Zhang QW, Ye WC, Wang YT*. Quantification and separation of protopanaxatriol and protopanaxadiol type saponins from Panax notoginseng with macroporous resins. Separation and Purification Technology. 2008, 60(2): 198-205. (IF=2.503)
  179. Sa F, Gao JL, Fung KP, Zheng Y, Lee SMY, Wang YT. Anti-proliferative and pro-apoptotic effect of Smilax glabra Roxb. extract on hepatoma cell lines. Chemico-Biological Interactions. 2008, 171(1): 1-14. (IF=3.077)
  180. Luo XJ, Wang CZ, Chen J, Song WX, Luo JY, Tang N, He BC, Kang Q, Wang YT, Du W, He TC, Yuan CS. Characterization of gene expression regulated by American ginseng and ginsenoside Rg3 in human colorectal cancer cells. International Journal of Oncology. 2008, 32(5): 975-983. (IF=2.234)
  181. Liu AL, Wang HD, Lee SMY, Wang YT, Du GH. Structure-activity relationship of flavonoids as influenza virus neuraminidase inhibitors and their in vitro anti-viral activities. Bioorganic & Medicinal Chemistry. 2008, 16(15): 7141-7147. (IF=3.075)
  182. Liu AL, Liu B, Qin HL, Lee SMY, Wang YT, Du GH. Anti-influenza virus activities of flavonoids from the medicinal plant Elsholtzia rugulosa. Planta Medica. 2008, 74(8): 847-851. (IF=1.960)
  183. Li Z, Hu Y, Ming LW, Chun CM, Ping PY, Ge L, Wang YT, Zhong Z, Fan HY. Selective and sensitive determination of bis(7)-tacrine, a high erythrocyte binding acetylcholinesterase inhibitor, in rat plasma by high-performance liquid chromatography-tandem mass spectrometry. Biomedical Chromatography. 2008, 22(4): 414-420. (IF=1.592)
  184. Li P, Xu G, Li SP, Wang YT, Fan TP, Zhao QS, Zhang QW. Optimizing ultra performance liquid chromatographic analysis of 10 diterpenoid compounds in Salvia miltiorrhiza using central composite design. Journal of Agricultural and Food Chemistry. 2008, 56(4): 1164-1171. (IF=2.562)
  185. Lam HW, Lin HC, Lao SC, Gao JL, Hong SJ, Leong CW, Yue PYK, Kwan YW, Leung AYH, Wang YT*, Lee SMY. The angiogenic effects of Angelica sinensis extract on HUVEC in vitro and zebrafish in vivo. Journal of Cellular Biochemistry. 2008, 103(1): 195-211. (IF=3.540)
  186. Hu YJ, Bian Y, Wang YT*. Opening the Black Box of Pharmaceutical Patent Value: An Empirical Analysis. Drug Information Journal. 2008, 42(6): 561-568. (IF=0.504)
  187. Gao JL, Shi JM, He K, Zhang QW, Li SP, Lee SMY, Wang YT*. Yanhusuo extract inhibits metastasis of breast cancer cells by modulating mitogen-activated protein kinase signaling pathways. Oncology Reports. 2008, 20(4): 819-824. (IF=1.524)
  188. Chen XJ, Ji H, Zhang QW, Tu PF, Wang YT, Guo BL, Li SP. A rapid method for simultaneous determination of 15 flavonoids in Epimedium using pressurized liquid extraction and ultra-performance liquid chromatography. Journal of Pharmaceutical and Biomedical Analysis. 2008, 46(2): 226-235. (IF=2.629)
  189. Chen XJ, Ji H, Wang YT, Li SP. Simultaneous determination of seven flavonoids in Epimedium using pressurized liquid extraction and capillary electrochromatography. Journal of Separation Science. 2008, 31(5): 881-887. (IF=2.746)
  190. Yu H, Ho JMK, Kan KKW, Cheng BWH, Li WM, Zhang L, Lin G, Pang YP, Gu ZM, Chan K, Wang YT*, Han YF. Development of a high performance liquid chromatography-tandem mass method for determination of bis(7)-tacrine, a promising anti-Alzheimer's dimer, in rat blood. Journal of Pharmaceutical and Biomedical Analysis. 2007, 44(5): 1133-1138. (IF=2.761)
  191. Yang FQ, Li SP, Zhao J, Lao SC, Wang YT. Optimization of GC-MS conditions based on resolution and stability of analytes for simultaneous determination of nine sesquiterpenoids in three species of Curcuma rhizomes. Journal of Pharmaceutical and Biomedical Analysis. 2007, 43(1): 73-82. (IF=2.761)
  192. Yang FQ, Li SP, Li P, Wang YT. Optimization of CEC for simultaneous determination of eleven nucleosides and nucleobases in Cordyceps using central composite design. Electrophoresis. 2007, 28(11): 1681-1688. (IF=3.609)
  193. Xiao Y, Yang FQ, Li SP, Gao JL, Hu G, Lao SC, Conceicao EL, Fung KP, Wang YT*, Lee SMY. Furanodiene induces G(2)/M cell cycle arrest and apoptosis through MAPK signaling and mitochondria-caspase pathway in human hepatocellular carcinoma cells. Cancer Biology & Therapy. 2007, 6(7): 1044-1050. (IF=2.873)
  194. Wan JB, Li SP, Chen JM, Wang YT*. Chemical characteristics of three medicinal plants of the Panax genus determined by HPLC-ELSD. Journal of Separation Science. 2007, 30(6): 825-832. (IF=2.632)
  195. Qin NY, Yang FQ, Wang YT, Li SP. Quantitative determination of eight components in rhizome (Jianghuang) and tuberous root (Yujin) of Curcuma longa using pressurized liquid extraction and gas chromatography-mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis. 2007, 43(2): 486-492. (IF=2.761)
  196. Liu AL, Guang HM, Zhu LY, Du GH, Lee SMY, Wang YT. 3D-QSAR analysis of a new type of acetylcholinesterase inhibitors. Science in China Series C-Life Sciences. 2007, 50(6): 726-730. (IF=0.635)
  197. Li P, Li SP, Yang FQ, Wang YT*. Simultaneous determination of four tanshinones in salvia miltiorrhiza by pressurized liquid extraction and capillary electrochromatography. Journal of Separation Science. 2007, 30(6): 900-905. (IF=2.632)
  198. Leong CW, Wong CH, Lao SC, Leong EC, Lao LF, Law PTW, Fung KP, Tsang KS, Waye MMY, Tsui SKW, Wang YT*, Lee SMY. Effect of resveratrol on proliferation and differentiation of embryonic cardiomyoblasts. Biochemical and Biophysical Research Communications. 2007, 360(1): 173-180. (IF=2.749)
  199. Jiang Y, Li P, Li SP, Wang YT, Tu P. Optimization of pressurized liquid extraction of five major flavanoids from Lysimachia clethroide. Journal of Pharmaceutical and Biomedical Analysis. 2007, 43(1): 341-345. (IF=2.761)
  200. Gao JL, Leung KSY, Wang YT, Lai CM, Li SP, Hu LE, Lu GH, Jiang ZH, Yu ZL. Qualitative and quantitative analyses of nucleosides and nucleobases in Ganoderma spp. by HPLC-DAD-MS. Journal of Pharmaceutical and Biomedical Analysis. 2007, 44(3): 807-811. (IF=2.761)
  201. Chen XJ, Guo BL, Li SP, Zhang QW, Tu PF, Wang YT*. Simultaneous determination of 15 flavonoids in Epimedium using pressurized liquid extraction and high-performance liquid chromatography. Journal of Chromatography A. 2007, 1163(1-2): 96-104. (IF=3.641)
  202. Hu YJ, Ung COL, Bian Y, Wang YT*. Marketing StrategyThe Chinese pharmaceutical market: Dynamics and a proposed investment strategy. Journal of Medical Marketing. 2007, 7(1): 18-24.
  203. Hu YJ, Geng F, Bian Y, Wang YT*. The Chinese pharmaceutical market: Perspectives of the health consumer. Journal of Medical Marketing. 2007, 7(4): 295-300.
  204. Yu Y, Zhang QW, Wang YT, Li SP. A rapid HPLC method for determination of coniferyl ferulate in Angelica sinensis and Ligusticum chuanxiong. Journal of Chinese Pharmaceutical Sciences. 2007, 16(3): 197-201.
  205. Wang J, Wang YT, Li SP. Simultaneous determination of five nucleosides and nucleobases in Panax notoginseng using high-performance liquid chromatography. Journal of Chinese Pharmaceutical Sciences. 2007, 16(2): 79-83.
  206. Liu AL, Lee SMY, Wang YT, Du GH. Elsholtzia: review of traditional uses,chemistry and pharmacology. Journal of Chinese Pharmaceutical Sciences. 2007, 16(2): 73-78.
  207. Zhao J, Zhang XQ, Li SP, Yang FQ, Wang YT, Ye WC. Quality evaluation of Ganoderma through simultaneous determination of nine triterpenes and sterols using pressurized liquid extraction and high performance liquid chromatography. Journal of Separation Science. 2006, 29(17): 2609-2615. (IF=2.535)
  208. Zhao J, Li SP, Yang FQ, Li P, Wang YT. Simultaneous determination of saponins and fatty acids in Ziziphus jujuba (Suanzaoren) by high performance liquid chromatography-evaporative light scattering detection and pressurized liquid extraction. Journal of Chromatography A. 2006, 1108(2): 188-194. (IF=3.554)
  209. Yu L, Zhao J, Li SP, Fan H, Hong M, Wang YT, Zhu Q. Quality evaluation of Cordyceps through simultaneous determination of eleven nucleosides and bases by RP-HPLC. Journal of Separation Science. 2006, 29(7): 953-958. (IF=2.535)
  210. Yang FQ, Wang YT, Li SP. Simultaneous determination of 11 characteristic components in three species of Curcuma rhizomes using pressurized liquid extraction and high-performance liquid chromatography. Journal of Chromatography A. 2006, 1134(1-2): 226-231. (IF=3.554)
  211. Wan JB, Yang FQ, Li SP, Wang YT, Cui XM. Chemical characteristics for different parts of Panax notoginseng using pressurized liquid extraction and HPLC-ELSD. Journal of Pharmaceutical and Biomedical Analysis. 2006, 41(5): 1596-1601. (IF=2.032)
  212. Wan JB, Li P, Li SP, Wang YT, Dong TTX, Tsim KWK. Simultaneous determination of 11 saponins in Panax notoginseng using HPLC-ELSD and pressurized liquid extraction. Journal of Separation Science. 2006, 29(14): 2190-2196. (IF=2.535)
  213. Wan JB, Lai CM, Li SP, Lee MY, Kong LY, Wang YT*. Simultaneous determination of nine saponins from Panax notoginseng using HPLC and pressurized liquid extraction. Journal of Pharmaceutical and Biomedical Analysis. 2006, 41(1): 274-279. (IF=2.032)
  214. Liu JJ, Li SP, Wang YT. Optimization for quantitative determination of four flavonoids in Epimedium by capillary zone electrophoresis coupled with diode array detection using central composite design. Journal of Chromatography A. 2006, 1103(2): 344-349. (IF=3.554)
  215. Li SP, Zhang GH, Zeng Q, Huang ZG, Wang YT, Dong TTX, Tsim KWK. Hypoglycemic activity of polysaccharide, with antioxidation, isolated from cultured Cordyceps mycelia. Phytomedicine. 2006, 13(6): 428-433. (IF=1.403)
  216. Li P, Li SP, Wang YT. Optimization of CZE for analysis of phytochemical bioactive compounds. Electrophoresis. 2006, 27(23): 4808-4819. (IF=4.101)
  217. Li P, Li SP, Lao SC, Fu CM, Kan KKW, Wang YT*. Optimization of pressurized liquid extraction for Z-ligustilide, Z-butylidenephthalide and ferulic acid in Angelica sinensis. Journal of Pharmaceutical and Biomedical Analysis. 2006, 40(5): 1073-1079. (IF=2.032)
  218. Lai CM, Li SP, Yu H, Wan JB, Kan KW, Wang YT*. A rapid HPLC-ESI-MS/MS for qualitative and quantitative analysis of saponins in "XUESETONG" injection. Journal of Pharmaceutical and Biomedical Analysis. 2006, 40(3): 669-678. (IF=2.032)
  219. Jiang Y, Li SP, Chang HT, Wang YT, Tu PF. Pressurized liquid extraction followed by high-performance liquid chromatography for determination of seven active compounds in Cortex Dictamni. Journal of Chromatography A. 2006, 1108(2): 268-272. (IF=3.554)
  220. Hu LF, Li SP, Cao H, Liu JJ, Gao JL, Yang FQ, Wang YT*. GC-MS fingerprint of Pogostemon cablin in China. Journal of Pharmaceutical and Biomedical Analysis. 2006, 42(2): 200-206. (IF=2.032)
  221. Fan H, Li SP, Xiang JJ, Lai CM, Yang FQ, Gao JL, Wang YT. Qualitative and quantitative determination of nucleosides, bases and their analogues in natural and cultured Cordyceps by pressurized liquid extraction and high performance liquid chromatography-electrospray ionization tandem mass spectrometry (HPLC-ESI-MS/MS). Analytica Chimica Acta. 2006, 567(2): 218-228. (IF=2.894)
  222. Yang FQ, Li SP, Chen Y, Lao SC, Wang YT, Dong TTX, Tsim KWK. Identification and quantitation of eleven sesquiterpenes in three species of Curcuma rhizomes by pressurized liquid extraction and gas chromatography-mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis. 2005, 39(3-4): 552-558. (IF=1.889)
  223. Wan JB, Xu C, Li SP, Kong LY, Wang YT*. Studies on the pressurized solvent extraction of isoflavonoids from Pueraria lobata. Chinese Journal of Analytical Chemistry. 2005, 33(10): 1435-1438. (IF=0.397)
  224. Liu AL, Wang YT, Du GH. Neuraminidase as a target for drugs for the treatment of influenza. Drugs of the Future. 2005, 30(8): 799-806. (IF=0.547)
  225. Gong YX, Li SP, Wang YT, Li P, Yang FQ. Simultaneous determination of anthraquinones in rhubarb by pressurized liquid extraction and capillary zone electrophoresis. Electrophoresis. 2005, 26(9): 1778-1782. (IF=3.850)
  226. Yu Z, Jiang B, Wang YT, Shi LW. Current Status and Development Strategies of TCMM Exportation in China. Journal of Chinese Pharmaceutical Sciences. 2005, 14(1): 65-68.
  227. Li XZ, Jiang B, Wang YT, Shi LW. Current Status and Development Strategies of Chinese Cosmetic Industry. Journal of Chinese Pharmaceutical Sciences. 2005, 14(1): 72-74.
  228. Li SP, Li P, Lai CM, Gong YX, Kan KKW, Dong TTX, Tsim KWK, Wang YT. Simultaneous determination of ergosterol, nucleosides and their bases from natural and cultured Cordyceps by pressurised liquid extraction and high-performance liquid chromatography. Journal of Chromatography A. 2004, 1036(2): 239-243. (IF=3.359)
  229. Lao SC, Li SP, Kan KKW, Li P, Wan JB, Wang YT*, Dong TTX, Tsim KWK. Identification and quantification of 13 components in Angelica sinensis (Danggui) by gas chromatography-mass spectrometry coupled with pressurized liquid extraction. Analytica Chimica Acta. 2004, 526(2): 131-137. (IF=2.588)
  230. Gong YX, Li SP, Li P, Liu JJ, Wang YT. Simultaneous determination of six main nucleosides and bases in natural and cultured Cordyceps by capillary electrophoresis. Journal of Chromatography A. 2004, 1055(1-2): 215-221. (IF=3.359)

Chinese peer-reviewed journals

  1. Yu XW, Xhang XT, Hu H, Wang YT. Technological analysis and forecasting of fibrates between America, Europe and China – Based on patent analysis. Journal of Intelligence. 2014, 33(2): 44-47.
  2. Ni JY, Cai Y, Li ZJ, Hu YJ, Wang YT. Research on current situation and strategies of university technology transfer in China. Science and Technology Management Research. 2014, (5): 189-193.
  3. Ma ZQ, Yang N, Hu H, Wang YT, Aerpati S. Knowledge based transfer and transformation of traditional industry: A case study of Uygur medicine industry in Xinjiang. Science & Technology Progress and Policy. 2014, 31(2): 144-148.
  4. Jing WH, Wu WJ, Yan R,, Wang YT*. Research progress in chemical, pharmacological and pharmacokinetic studies of Mori Cortex, a Chinese medicinal herb belonging to lung meridian. World Chinese Medicine. 2014, 9(1): 109-112,116.
  5. Chen YN, Yu XW, Hu H, Wang YT. Comparison of technology and institutional distribution of fibrates between America, Europe and China base on patent analysis. Chinese Journal of New Drugs. 2014, 23(6): 631-634,639.
  6. Zhang JL, Yu XW, Hu H, Wang YT. Comparison of basic service by community pharmacies in New York of USA, Macao and Zhuhai of China.. Pharmaceutical Care and Research. 2013, 13(2): 143-146.
  7. Yu YY, Feng L, Liu JJ, Qiu L, Hu YJ, Wang YT*. A global market analysis of antitumor drugs. Chinese Pharmaceutical Journal. 2013, 48(2): 155-158.
  8. Shen D, Chen MW, Wang SP, Li P, Wang YT*. Progress in novel drug delivery systems of anti-tumor traditional Chinese medicine – Blood-activating and stasis-resolving Chinese medicine. World Science and Technology/Modernization of Traditional Chinese Medicine and Materia Medica. 2013, 15(1): 34-39.
  9. Ni JY, Cai Y, Xu JC, Hu YJ, Wang YT. Exploration of strategies on patent licensing and Chinese materia medica internationalization. Chinese Traditional and Herbal Drugs. 2013, 44(21): 3080-3083.
  10. Ma ZQ, Zhang MY, Hu H, Wang YT. Research advances of Uighur patent medicine in Xinjiang: Based on patent applications and academic publications. Chinese Journal of Ethnomedicine and Ethnopharmacy. 2013, (15): 4-7.
  11. Ma ZQ, Zhang MY, Chen MW, Hu H, Wang YT. An overview of the research on Uighur crude medicine in Xinjiang: Based on patent applications and academic publications. Journal of Chinese Medicinal Materials. 2013, 36(12): 2071-2074.
  12. Ma ZQ, Yu YY, Hu H, Wang YT. Government actions of Chinese pharmaceutical industry clusters in view of local policy. Science and Technology Management Research. 2013, (14): 40-44.
  13. Liu JJ, Yu YY, Qiu L, Wang YT. Study on the influence and the relationship network of those who disseminate nutritional information on Sina Weibo. Knowledge Management Forum. 2013, (6): 7-14.
  14. Liu JJ, Yu YY, Qiu L, Wang YT*. Analysis of status quo of geographical indications registration of traditional Chinese drugs. China Pharmacy. 2013, 24(3): 193-195.
  15. Chen RE, Wang SP, Hu YY, Chen MW, Wang YT*. Progress in novel drug delivery system of anti-tumor Chinese medicine (Part three)—Fuzheng Guben Chinese medicine. World Science and Technology/Modernization of Traditional Chinese Medicine and Materia Medica. 2013, 15(2): 201-206.
  16. Cai Y, Hu H, Ni JY, Wang YT. Development of quality traceability system of traditional Chinese medicine. China Journal of Chinese Meteria Medica. 2013, 38(22): 3829-3833.
  17. Zhang N, Zhang L, Wang YT. Branding strategy research on China’s generic drugs. Science and Technology Management Research. 2012, (23): 108-112.
  18. Zhang JL, Ge S, Hu H, Wang YT*. Comparative study of medical service of community pharmacy in Zhuhai, Macao and New York. China Medical Herald. 2012, 9(27): 129-131.
  19. Yu XW, Fu YY, Hu H, Wang YT. Innovative choice on Chinese patent medicinal products from the commercial persepctive. Chinese Journal of Pharmacentical Technolgy Economics and Management. 2012, (4): 54-58.
  20. Xu WS, Lu JJ, Chen XP, Wang YT*. Anti-cancer drug research and development based on endoplasmic reticulum stress. Chinese Pharmacological Bulletin. 2012, 28(12): 1659-1665.
  21. Xu WS, Huang MQ, Chen XP, Wang YT*. Research progress of aromatase inhibitors from natural products. Lishizhen Medicine and Materia Medica Research. 2012, 23(4): 1008-1011.
  22. Wang YT, Pan W, Liu JJ, Chen MW. Joint development of the novel traditional Chinese medicine technology industrial park by Guangdong and Macau. Science & Technology Industry of China. 2012, (9): 62-65.
  23. Wang SP, Shen DY, Li P, Chen MW, Wang YT*. Progress in novel drug delivery systems of antitumor Chinese medicinals—Qingre Jiedu Chinese Medicinals. World Science and Technology/Modernization of Traditional Chinese Medicine and Materia Medica. 2012, 14(6): 2131-2135.
  24. Wang SP, Hu YY, Chen RE, Zhong ZF, Chen MW, Wang YT*. Systematic study of Chinese medicine herb pairs (II) — Pharmacodynamics and pharmacokinetics study. World Science and Technology/Modernization of Traditional Chinese Medicine and Materia Medica. 2012, 14(2): 1322-1328.
  25. Wang SP, Chen MW, Wang YT*. Research progress on chemical constituents and pharmacological activities of FIos Puerariae. Pharmacology and Clinics of Chinese Materia Medica. 2012, 28(2): 193-196.
  26. Wang SP, Chen MW, Wang YT*. Systematic study of Chinese medicine herb pairs (I) — Theory and material basis study. World Science and Technology/Modernization of Traditional Chinese Medicine and Materia Medica. 2012, 14(2): 1317-1321.
  27. Shi HH, Hu H, Wang YT. Analysis on cooperation between pharmaceutical companies in China from the perspective of competition and cooperation theory. Science and Technology Management Research. 2012, (5): 116-118, 123.
  28. Shi HH, Hu H, Wang YT. Probe into the development path of China monoclonal antibody products from business model. Science and Technology Management Research. 2012, (21): 111-114.
  29. Shi YZ, Hu H, Wang YT. Independent R&D or external acquisition? Technical considerations for the business model of Chinese biopharmaceuticals. Journal of Management Case Studies. 2012, 5(3): 205-212.
  30. Pan W, Li L, Hu YJ, Wang YT. Pharmaceutical R&D and enterprise performance – Quantitative analysis on big pharmas’ drug development pipeline. Science & Technology Progress and Policy. 2012, 29(8): 91-94.
  31. Lu JJ, Huang MQ, Chen XP, Wang YT*. Application of expression proteomics in the research and development of anti-cancer drugs. Chinese Journal of New Drugs. 2012, 21(1): 43-47.
  32. Lu JJ, Huang MQ, Chen XP, Wang YT*. Progress in anti-neoplastic effects and mechanisms of dihydroartemisinin. Chinese Journal of Pharmacology and Toxicology. 2012, 26(3): 397-401.
  33. Li XW, Gao HH, Wang YT, Song JY, Robert H, Wu HZ, Hu ZG, Yao H, Luo HM, Luo K, Pan HL, Chen SL. Complete chloroplast genome sequence of Magnolia grandiflora and comparative analysis with related species. Science China-Life Sciences. 2012, 42(12): 947-956.
  34. Lai YF, Lu JJ, Chen XP, Hu H, Wang YT*. Analysis of anti-cancer traditional Chinese medicine injections based on market performance. World Science and Technology/Modernization of Traditional Chinese Medicine and Materia Medica. 2012, 14(5): 1958-1962.
  35. Huang MQ, Xu W, Chu KD, Lu JJ, Chen XP, Wang YT. Recent advances on Chinese medicine and active ingredients in ameliorating insulin resistance via GLUT4 translocation. Chinese Journal of Experimental Medical Formulae. 2012, 18(16): 343-346.
  36. Hu YY, Wang SP, Chen RE, Chen MW, Wang YT*. Research progress on pharmaceutical research and applications of Penthorum chinense Pursh. Pharmacology and Clinics of Chinese Materia Medica. 2012, 28(3): 136-140.
  37. Hu YY, Chen RE, Wang SP, Chen MW, Wang YT*. Systematic study of Chinese medicine herb pairs (VI) — Herb pair of Radix Astragali and Angelica Sinensis. World Science and Technology/Modernization of Traditional Chinese Medicine and Materia Medica. 2012, 14(2): 1349-1356.
  38. Guo Y, Liu C, Hu YJ, Wang YT. Analysis on the layout of Chinese patents from foreign pharmaceutical companies. Chinese Journal of Pharmaceuticals. 2012, 43(12): A124-A127.
  39. Gong J, Wang SP, Chen MW, Wang YT*. Systematic study of Chinese medicine herb pairs (III) — Pharmaceutical theory and novel herb-pair formulations. World Science and Technology/Modernization of Traditional Chinese Medicine and Materia Medica. 2012, 14(2): 1329-1333.
  40. Gao JL, Chen ZF, Shi JM, Wang YT, Lü GY. Content determination of 5 kinds of alkaloids in Corydalis yanhusuo and stability study. China Pharmacy. 2012, 23(15): 1386-1388.
  41. Feng L, Cao C, Yu YY, Hu YJ, Wang YT*. Analysis of the 26 kinds of withdrawal drug during 1991-2010. China Pharmacy. 2012, 23(33): 3158-3159.
  42. Chen XP, Lu JJ, Guo JJ, Bao JL, Xu WS, Ding Q, Wang YT. Inspirations from natural products based drug research and development for Chinese medicine research—Analysis of natural products recorded in TTD. Acta Pharmaceutica Sinica. 2012, 47(11): 1423-1427.
  43. Chen RE, Shen DY, Li P, Wang SP, Hu YY, Chen MW, Wang YT*. Systematic study of Chinese medicine herb pairs (V) — Herb pair of Salvia Miltrorrhiza and Panax Notoginseng. World Science and Technology/Modernization of Traditional Chinese Medicine and Materia Medica. 2012, 14(2): 1342-1348.
  44. Chen RE, Hu YY, Wang SP, Chen MW, Wang YT*. Systematic study of Chinese medicine herb pairs (IV)— Herb pair of Coptis Chinensis and Euodia Rutaecarpa. World Science and Technology/Modernization of Traditional Chinese Medicine and Materia Medica. 2012, 14(2): 1334-1341.
  45. Chen MW, Zhong ZF, Wang SP, Wang YT*. Research progress in anticancer activity and novel delivery system of β-elemene. Chinese Journal of New Drugs. 2012, 21(12): 1358-1361, 1388.
  46. Chen MW, Chen WR, Chen TK, Chen RE, Wang YT*. Application research of hot-melt extrusion in preparation of solid dispersion. Acta Pharmaceutica Sinica. 2012, 47(2): 163-167.
  47. Chen C, Yu YY, Hu YJ, Wang YT*. Analysis on layout of traditional Chinese medicine industry based on location quotient. China Journal of Chinese Meteria Medica. 2012, 37(5): 549-552.
  48. Chen C, Hu YJ, Wang YT*. Impact of the aging of population on public healthcare expenses in China. Chinese Journal of Health Statistics. 2012, 29(3): 430-432.
  49. Chao F, Qiu L, Hu YJ, Wang YT*. Empirical study on the impact of ERP implementation to the performance of listed pharmaceutical companies. China Pharmacy. 2012, 23(5): 387-390.
  50. Cao C, Liu JJ, Hu YJ, Wang YT. Analysis of the business value of traditional Chinese medicine based on technology, business and law. Journal of Nanjing University of TCM (Social Science). 2012, 13(2): 111-115.
  51. Bao JL, Lu JJ, Chen XP, Wang YT*. Research progress in the anti-tumor effects and mechanisms of matrine and oxymatrine. Traditional Chinese Drug Research & Clinical Pharmacology. 2012, 23(3): 369-373.
  52. Zhao Y, Hu H, Wang YT*. Approaches for industry upgrade of Chinese pharmaceutical enterprises based on relevant cases from developing countries. China Pharmacy. 2011, 22(33): 3076-3078.
  53. Zhang SK, Hu YJ, Yin H, Wang YT. Drug targets and economic value: an empirical study based on new drugs marketed in US during recent ten years. Science and Technology Management Research. 2011, (23): 172-175.
  54. Zhang SK, Hu YJ, Liu JJ, Wang YT. Collaborative innovation model of traditional Chinese medicinal pharmaceutical enterprises. Science and Technology Management Research. 2011, (10): 88-91.
  55. Yu WX, Shi LW, Wang YT. On the problems of current medical reserve system and some policy proposal for system reformation in China. China Pharmacy. 2011, 22(9): 780-782.
  56. Yu WX, Hu H, Shi LW, Wang YT. Research on the behaviour of integrating external resource in the R&D oriented pharmaceutical companies of China. Science & Technology Progress and Policy. 2011, 28(4): 85-89.
  57. Yu YY, Liu JJ, Bian Y, Wang YT. Equity analysis of hospital beds distribution in Mainland China. Chinese Health Resources. 2011, 14(6): 394-396.
  58. Xiong XL, Zheng Y, Wang YT. Application of solid dispersion combined with carriers for in vitro release of multi-components from Danshen extract. Chinese Traditional and Herbal Drugs. 2011, 42(1): 50-55.
  59. Sun J, Yin ZQ, Zhang QW, Ye WC, Wang YT, Zhao SX. Chemical constituents from ethyl acetate extract of Ganoderma lucidum. Journal of China Pharmaceutical University. 2011, 42(3): 220-222.
  60. Su WP, Song RL, Wang YT, Shi LW. Strategy for development of generic drug superstars in China. Chinese Journal of New Drugs. 2011, 20(3): 200-203.
  61. Song Y, Hu YJ, Bian Y, Wang YT. Correlation between the technical value and the economic value of drugs. China Pharmacy. 2011, 22(13): 1153-1155.
  62. Qiu L, Yu YY, Liu JJ, Wang YT. Empirical analysis on the circulation of Hong Kong dollars in Macau in recent years. Special Zone Economy. 2011, (10): 13-15.
  63. Qiu L, Hu YJ, Wang YT. Development status and investment prospects of for-profit healthcare organizations. Economic Herald. 2011, (6): 55-57.
  64. Qiu L, Hu YJ, Wang YT. Analysis on the liability insurance regarding drug-induced health care issues. Insurance Studies. 2011, (6): 82-87.
  65. Pan W, Hu YJ, Wang YT*. Globalization of acupuncture technology innovation: a quantitative analysis based on acupuncture patents in the U. S. A. Chinese Acupuncture & Moxibustion. 2011, 31(8): 749-752.
  66. Li L, Pan W, Hu YJ, Wang YT*. Exploration of the development of the cosmeceutical market in the Chinese pharmaceutical industry. Enterprise Economy. 2011, (8): 83-85.
  67. He PW, Du G, Zhao HY, Wang YT*. Determination of four mineral elements in nine Chinese medicines by graphite furnace atomic absorption spectrometry coupled with microwave digestion. China Journal of Traditional Chinese Medicine and Pharmacy. 2011, 26(2): 271-274.
  68. Fu S, Lu JJ, Chen XP, Wang YT*. Research progress on the anti-cancer activity of terpenoids isolated from Rhizoma Curcumae. West China Journal of Pharmaceutical Sciences. 2011, 26(6): 604-606.
  69. Chen XP, Zhong ZF, Xu ZT, Yan R, Li PT, Wang YT*. Material basis-based pharmacokinetic investigation of Chinese medicine. World Science and Technology/Modernization of Traditional Chinese Medicine and Materia Medica. 2011, 13(1): 137-142.
  70. Chen XP, Pei LX, Wang YT. Discussion on research and development models in innovative Chinese materia medica. Chinese Traditional and Herbal Drugs. 2011, 42(7): 1255-1260.
  71. Chen XP, Hu YJ, Wang YT*. Reflection on Chinese medicine formula innovative studies - Comment on the first publication of Chinese medicine formula in science translational medicine. World Science and Technology/Modernization of Traditional Chinese Medicine and Materia Medica. 2011, 13(4): 704-706.
  72. Chen MW, Chen WR, Li SY, Wang SP, Zhong ZF, Wang YT*. Research progress on chemical constituents and pharmacological activities of Alocasia macrorrhiza. Pharmacology and Clinics of Chinese Materia Medica. 2011, 27(3): 128-131.
  73. Chen MW, Chen RE, Li YB, Tan W, Wang YT*. Research and application in nanoparticle formulation of oridonin. Chinese Journal of Experimental Medical Formulae. 2011, 17(16): 284-287.
  74. Chen C, Hu YJ, Wang YT*. Analyzing the positive factors contributing to income of medical services in China. Chinese Health Service Management. 2011, (5): 326-328.
  75. Chao F, Hu YJ, Wang YT*. Analysis of the strategy and factors affecting the success of implementing ERP in pharmaceutical industry in China. China Pharmacy. 2011, 22(41): 3841-3843.
  76. Zhong ZF, Chen XP, Wu T, Wang YT*. Research progress of curcumenol. China Pharmacy. 2010, 21(31): 2959-2961.
  77. Yao JR, Bian Y, Wang YT, Xie DH. Analysis of 2216 inpatient fatality cases from a large Grade A Class 3 hospital in the South of China. Chinese Journal of Health Statistics. 2010, 27(6): 630-631.
  78. Yao JR, Bian Y, Wang YT, Sun Y, Luo SK. Thinking and exploration of the development of hospital pharmacy in China under the new medical reform model. Chinese Hospital Management. 2010, 30(3): 52-53.
  79. Wu X, Bi Y, Wang YT*. Progress on chemical compositions and pharmacological action of Peucedanum praeruptorum Dunn. Food and Drug. 2010, 12(11): 442-445.
  80. Su WP, Hu H, Shi LW, Wang YT. Development andmarketing strategies ofme too drug. Chinese Journal of New Drugs. 2010, 19(11): 926-929.
  81. Peng XT, Hu H, Wang YT. Brand management strategy: The reasons for the success of “Wong Lo Ka t”. Enterprise Vitality. 2010, (3): 28-32.
  82. Peng XT, Hu H, Wang YT. Path selection of innovation of TCM enterprises: Hong Kong Vita Green and PuraPharm as case studies. Special Zone Economy. 2010, (5): 287-289.
  83. Peng XT, Hu H, Wang YT. TCM enterprise innovation system construction experience of PuraPharm. Enterprise Vitality. 2010, (8): 23-27.
  84. Pan W, Hu YJ, Wang YT*. Analysis on Chinese patent application of multi-national medical companies. Science and Technology Management Research. 2010, (22): 190-192, 195.
  85. Li X, Wan JB, Lee MY, Wang YT. Progress in the pharmaceutical study of Radix puerariae. Chinese Journal of New Drugs. 2010, 19(8): 662-665.
  86. Li L, Zhang YR, Hu YJ, Wang YT*. Analysis of global blockbuster drugs based on disease, medicine and market factors. Chinese Journal of Pharmaceuticals. 2010, 41(9): 709-713.
  87. Li GH, Zhang QW, Wang YT. Chemical constituents from roots of Pueraria lobata. China Journal of Chinese Meteria Medica. 2010, 35(23): 3156-3160.
  88. Huang ZH, Hu H, Wang YT. Analysis of the pathways for technology spillovers of multinational pharmaceutical companies in China. Productivity Research. 2010, (8): 125-126, 144.
  89. Hu H, Fan MX, Wang YT. Analysis of the industrial value chain positioning of China CRO enterprises and the innvoation capability of the pharmaceutical industry. Chinese Journal of Pharmacentical Technolgy Economics and Management. 2010, (5): 64-67.
  90. He XQ, Pei LX, Wang YT, Zheng Y. Study on pharmacokinetics of baicalein by HPLC-UV after intragastric administration in rats. Chinese Journal of Hospital Pharmacy. 2010, 30(22): 1901-1905.
  91. He PW, Zhao HY, Du G, Wang YT*. Application of gas chromatography for pesticide residues analysis in Chinese medicine. Chinese Journal of Experimental Medical Formulae. 2010, 16(2): 126-134.
  92. He PW, Du G, Zhao HY, Wang B, Wang YT*. Determination of five heavy metals in nine Chinese medicines by atomic absorption spectrometry coupled with microwave digestion. Chinese Journal of Pharmaceutical Analysis. 2010, 30(9): 1707-1712.
  93. Geng XN, Han S, Hu H, Shi LW, Wang YT. An analysis of evidence-based pharmaceutical economic evaluation. China Journal of Pharmaceutical Economics. 2010, (4): 40-45.
  94. Feng XM, Hu H, Wang YT. Business portfolio construction and its control under the enterprise group system. China Economic & Trade Herald. 2010, (19): 62.
  95. Fan MX, Hu H, Zhao HY, Wang YT. Study on the competitive advantage of contract research organizations in China. Forum on Science and Technology in China. 2010, (5): 36-40, 46.
  96. Chen XP, Xun KL, Wang YT*. Systematic pharmacological evaluation of material basis for efficacy of Chinese herbal formula. Chinese Traditional and Herbal Drugs. 2010, 41(1): 1-5.
  97. Zhang Y, Zheng Y, Wang YT. Application of improved quality evaluation method to Fufang Danshen products. Chinese Traditional Patent Medicine. 2009, 31(12): 1855-1860.
  98. Zhang XY, Wang YT. Analysis of constraints for Licorice use and is management strategy. Territory & Natural Resources Study. 2009, (3): 95-96.
  99. Zhang C, Hu H, Wang YT. The moral considerations of search engines as pharmaceutical media. Chinese Health Service Management. 2009, (7): 499-501.
  100. Yu WX, Shi LW, Wang YT. R&D/marketing integration in drug development. Chinese Journal of Pharmacentical Technolgy Economics and Management. 2009, 3(6): 55-60.
  101. Xu SM, Yang M, Liang XD, Wang YT, Zheng Y. Preparation and in vitro characterization of time-controlled matrine pellets for colonic delivery. Chinese Pharmaceutical Journal. 2009, 44(22): 1713-1718.
  102. Xie YH, Hu H, Tan R, Wang YT*. Genetic engineering technology and pharmacological evaluation of Chinese medicine. Chinese Journal of Natural Medicines. 2009, 7(6): 476-480.
  103. Tang RR, Bian Y, Wang YT. The current situation of adverse drug reactions of Chinese medicine and the prevention and regulation of the situation. Lishizhen Medicine and Materia Medica Research. 2009, 20(2): 492-494.
  104. Tang RR, Bian Y, Wang YT. The relationship between "Regulations on Protection of Traditional Chinese Medicines" and patent for the protection of Chinese medicine. Lishizhen Medicine and Materia Medica Research. 2009, 20(5): 1291-1293.
  105. Peng XT, Hu H, Wang YT. Study on the innovative R&D investment of multinational pharmaceutical enterprises in China. China Pharmaceuticals. 2009, 18(16): 13-14.
  106. He K, Gao JL, Zhao GS, Wang YT*. Significance of public governance in the construction of supply system of essential drugs. China Pharmacy. 2009, 20(14): 1041-1043.
  107. Fan MX, Zhao HY, Wang YT. The modern pharmacological research of Rhubarb and its application in integrated Chinese and Western medicine . Guide of China Medicine. 2009, 7(8): 41-42, 20.
  108. Fan MX, Hu H, Zhao HY, Wang YT*. The way of increase competitive strength on medical and pharmaceuticals sciences in international market - The study of current situation on Chinese R&D alliance. Chinese Journal of Pharmacentical Technolgy Economics and Management. 2009, 3(5): 38-45.
  109. Fan MX, Bian Y, Zhao HY, Wang YT*. Comparative studies on the policies of improving the quality of life of old people between China and Japan. Medicine and Philosophy(Humanistic & Social Medicine Edition). 2009, 30(7): 30-32.
  110. Du Z, Zheng Y, Lai CM, Wang YT, Tang HY. Research progress on the spray freeze-drying technology and its application in pharmaceutics. Chinese Pharmaceutical Journal. 2009, 44(10): 724-727.
  111. Dang YY, Chen XP, Zhang QW, Wang YT*. Recent advances in pharmacological effect of capsaicin. Pharmacology and Clinics of Chinese Materia Medica. 2009, 25(4): 84-89.
  112. Zhou MM, Yang K, Wang YT, Kou F. Influence of Dachuanxiong Fang on behavior and dural inflammation of rat migraine model. Pharmacology and Clinics of Chinese Materia Medica. 2008, 24(4): 9-10.
  113. Zhou MM, Yang K, Wang YT. Evaluation of the synergy effect of Rhizoma Gastrodiae and Rhizoma Chuanxiong from Dachuanxiongwan Fang for the treatment of migraine based on blood rheology and flow velocity. Pharmacology and Clinics of Chinese Materia Medica. 2008, 24(3): 6-8.
  114. Zhao Y, He XQ, Xi J, Ren K, Gong T, Wang YT, Zheng Y. Isolation, purification and stability evaluation of Z-ligustilide from the essential oil of Radix Angelicae Sinensis. West China Journal of Pharmaceutical Sciences. 2008, 23(5): 533-535.
  115. Zhang H, Wang YT*, Yan C, Zhang QW, Li SP. Rerearch progress and comparison between the pharmacological effect of Radix Angelica Sinensis and Rhizoma Chuanxiong. Lishizhen Medicine and Materia Medica Research. 2008, 19(2): 293-295.
  116. Zhang C, Hu H, Wang YT. Surveying the characteristic, action and developing strategy of medical media. Chinese Health Service Management. 2008, (7): 497-499.
  117. Yu N, Gao JL, Hong SJ, Lee SMY, Wang YT. Regression of atherosclerosis by l-THP in vitro. Pharmacology and Clinics of Chinese Materia Medica. 2008, 24(3): 27-29.
  118. Xie YH, Wang YT, Tan R. Technology foresight in biomedicine. Journal of Chengdu University of TCM. 2008, 30(4): 78-81.
  119. Xi WW, Lee MY, Wang NS, Bi SQ, Wang YT*. A review of clinical trials of Cimicifuga racemosa for the treatment of menopausal symptoms. Lishizhen Medicine and Materia Medica Research. 2008, 19(10): 2555-2557.
  120. Wang N, Wan JB, Lee MY, Wang YT*. Advances in studies on Panax notoginseng against atherosclerosis. Chinese Traditional and Herbal Drugs. 2008, 39(5): 787-790.
  121. Sun LK, Zhang C, Wang YT, Zhang ZY. Discussion on the market-oriented training mode of high-level pharmaceutical talents. Journal of Chengdu University of TCM (Educational Science Edition). 2008, 10(2): 1-3.
  122. Sun LK, Hu H, Wang YT. Study on the effectiveness of using the internet as a platform for prescription drug promotion. China Pharmaceuticals. 2008, 17(16): 11-12.
  123. Shi JM, Guan J, Zhang QW, Li SP, Ye WC, Wang YT*. Application of ultra performance liquid chromatography in pharmaceutical analysis. Chinese Journal of Pharmaceutical Analysis. 2008, 28(9): 1583-1588.
  124. Qin YP, Hu H, Wang YT*. Case comparison on internationalization strategies of traditional Chinese medicine enterprises. Chinese Journal of Pharmaceuticals. 2008, 39(11): 874-876.
  125. Liang QY, Zheng Y, Tang HY, Li SP, Wang YT. HPLC determination of aristolochic acids in plants of Aristolochia L. by static pressurized liquid extraction. Chinese Traditional and Herbal Drugs. 2008, 39(3): 364-368.
  126. Huang ZP, Wang YT*, Hu H, Hu YJ, Sun LK. Prospect of TCM development in Macau. World Science and Technology/Modernization of Traditional Chinese Medicine and Materia Medica. 2008, 10(2): 112-115.
  127. Hu YJ, Bian Y, Wang YT. The theoretical discussion on patent value. Science and Technology Management Research. 2008, (5): 246-249.
  128. Deng YH, Lee MY, Huang HQ, Wang YT. Research progress on the anti-atherosclerotic effect of resveratrol. Journal of Sun Yat-Sen University (Medical Sciences). 2008, 29(S2): 163-165.
  129. Chen XJ, Li SP, Wang YT, Tu PF. Comparison of quantitative determination of flavonoids in Herba Epimedii by HPLC, UPLC and CZE. Chinese Pharmaceutical Journal. 2008, 43(8): 624-628.
  130. Zhang Y, Hu G, Hong SJ, Lao SC, Lee SMY, Wang YT. The proangiogenic effect of Radix Astragali extract in human umbilical vein endothelial cells (HUVEC). Pharmacology and Clinics of Chinese Materia Medica. 2007, 23(2): 34-37.
  131. Yu H, Li WM, Kan KW, Chan KC, Wang YT, Han YF. Research progress on the pharmacokinetics of anti-Alzheimer's agents. Chinese Pharmaceutical Journal. 2007, 42(15): 1121-1125.
  132. Xiu C, Lee MY, Bi SQ, Wang YT*. Research progress on the main chemical constituents and pharmacological research of Semen Persicae. China Pharmacy. 2007, 18(24): 1903-1904.
  133. Xie JJ, Yu Y, Wang YT, Li SP. Simultaneous HPLC determination of 6 components in Angelica sinensis. Chinese Journal of Pharmaceutical Analysis. 2007, 27(9): 1314-1317.
  134. Wang W, Zhang QW, Ye WC, Wang YT. Isoquinoline alkaloids from the Rhizoma of Coptis chinensis. Chinese Journal of Natural Medicines. 2007, 5(5): 348-350.
  135. Ni JY, Bian Y, Wang YT. Comparative analysis on the status quo of the development of domestic and international CROs. Science & Technology Progress and Policy. 2007, 24(4): 198-200.
  136. Liu AL, Lee MY, Wang YT, Du GH. Research progress on pharmacologically active substances of Salvia miltiorrhiza. Chinese Pharmaceutical Journal. 2007, 42(9): 641-646.
  137. Liu AL, Guang HM, Zhu LY, Du GH, Lee SMY, Wang YT. 3D-QSAR analysis of a new type of acetylcholinesterase inhibitors. Science in China Series C-Life Sciences. 2007, 37(5): 503-507.
  138. Leng W, Zheng Y, Wang YT. Absorption mechanism of curcuma oil and the development of its oral formulation. Chinese Journal of Medicine. 2007, 7(3): 221-225.
  139. Leng W, Zheng Y, Li SP, Yang FQ, Wang YT. Study on absorption mechanisms of zedoary turmeric oil by Caco-2 cell model. Chinese Pharmaceutical Journal. 2007, 42(16): 1228-1232.
  140. Jin SC, Hu YJ, Wang YT*. Comparative analysis of the pharmaceutical industry in China, Europe and the United States – the structure, conduct and performance. Chinese Journal of Pharmaceuticals. 2007, 38(7): A79-A84.
  141. Jin SC, Hu YJ, Wang YT. Analysis of hospital’s non-price competition in China and possible solutions. China Pharmacy. 2007, 18(31): 2401-2402.
  142. Huang ZP, Wang YT, Bian Y. The“view of justice and interests”of Confucius and the way of hospital’s management. Medicine and Philosophy(Humanistic & Social Medicine Edition). 2007, 28(5): 40-42.
  143. Huang ZP, Wang YT. Promoting the development of internationalization of Chinese medicine via the platform of Hong Kong and Macao. Modern Chinese Medicine. 2007, 9(7): 4-7.
  144. Huang ZP, Wang YT. The sunshine online purchase of drugs in the Guangdong province. Health Economics Research. 2007, (8): 27-28.
  145. Huang ZP, Wang YT. Comparison of GMP for pharmaceutical products between European Union and China. Chinese Health Service Management. 2007, (8): 539-540.
  146. Hu YJ, Yu Z, Bian Y, Wang YT*. Correlation between patent opposition and the economic value of drugs. China Pharmacy. 2007, 18(19): 1449-1451.
  147. Hu YJ, Bian Y, Wang YT. Application of Lanjouw-Schankerman patent valuation model in the drug selection of pharmaceutical enterprises. Chinese Journal of Pharmaceuticals. 2007, 38(2): A20-A22.
  148. Hu YJ, Bian Y, Wang YT. Study on patent evaluation method without market bench marking—A classic example by Prof. Harhoff and others. Soft Science. 2007, 21(4): 17-20.
  149. Hong SJ, Wang YT, Lee MY. Research progress on the pharmacological and clinical research of Huperzine A. Pharmacology and Clinics of Chinese Materia Medica. 2007, 23(1): 83-86.
  150. Hong SJ, Wan JB, Zhang QW, Zhang Y, Hu G, Lao SCS, Lee SMY, Wang YT. Proangiogeneic effect of total saponins of Panax notoginseng in human umbilical vein endothelial cells (HUVEC). Pharmacology and Clinics of Chinese Materia Medica. 2007, 23(2): 28-30.
  151. Chen XJ, Zhang QW, Ji H, Wang YT, Tu PF, Li SP. Comparison of UV spectrophotometry and HPLC on quantitative determination of total flavonoids of Herba Epimedii. Chinese Journal of Pharmaceutical Analysis. 2007, 27(5): 625-630.
  152. Zhao J, Bian Y, Li SP, Wang YT*. Study on the marketization of chemical reference substances of Chinese medicines. West China Journal of Pharmaceutical Sciences. 2006, 21(3): 316-318.
  153. Yu Z, Bian Y, Hu YJ, Wang YT. Statistics of international market share of Chinese materia medica and differentiated analysis on the correlated concepts. China Pharmacy. 2006, 17(5): 328-330.
  154. Yang XM, Bian Y, Wang YT. Diversified development of chain drugstore. China Pharmacy. 2006, 17(11): 878-879.
  155. Xiao Y, Li SP, Wang YT. Progress in pharmacological research of Hong-Jing-Tian glycoside. Practical Journal of Clinical Medicine. 2006, 3(3): 98-99.
  156. Wang TL, Che MF, Wang YT. Case study on the intellectual property protection of international traditional medicine. Chinese Journal of New Drugs. 2006, 15(19): 1609-1612.
  157. Wan JB, Li SP, Wang YT*. RP-HPLC characteristics of Panax notoginseng. Acta Pharmaceutica Sinica. 2006, 41(11): 1090-1093.
  158. Sun LX, Bian Y, Wang YT. Analysis on illegal drug advertisements in China. Journal of Sichuan Continuing Education College of MS. 2006, 25(2): 144, 150.
  159. Sun LX, Bian Y, Wang YT. Improvement and development ofI pharmaceutical advertising regulatory system in China. Soft Science of Health. 2006, 20(5): 448-450.
  160. Sa F, Yu ZL, Wang YT. Research progress on the quality and pharmacological activities of Smilax glabra. Journal of Chinese Medicinal Materials. 2006, 29(5): 516-519.
  161. Sa F, Li SP, Wang YT. Research progress on first-aid dosage forms in Chinese medicine. Health Science Journal of Macao. 2006, 6(2): 127-130.
  162. Qiu L, Bian Y, Wang YT. Performance of listed companies after merger & acquisition in medical industry. China Pharmacy. 2006, 17(19): 1448-1451.
  163. Ni JY, Bian Y, Wang YT. TCM industry: Vital to sharpen competitiveness by innovation through cooperation. China Pharmaceuticals. 2006, 15(1): 9-10.
  164. Ni JY, Bian Y, Wang YT. Discussion on the new model of community health services. Health Economics Research. 2006, (6): 15-16.
  165. Ni JY, Bian Y, Wang YT. Application of project management in the R&D of new TCM drugs.. China Pharmaceuticals. 2006, 15(21): 13-15.
  166. Liu Y, Hu YJ, Bian Y, Wang YT*. The significance of establishing third-party certification on traditional Chinese medicine market. West China Journal of Pharmaceutical Sciences. 2006, 21(3): 319-320.
  167. Hu YJ, Zhao J, Shao R, Bian Y, Wang YT. Comparison of study development of pharmacy administration between the mainland, Hong Kong, Macao and Taiwan in China. Pharmaceutical Education. 2006, 22(2): 54-57.
  168. Kun SH, Bian Y, Wang YT. Characteristic of population aging and its health care analysis in Macao SAR. Chinese General Practice. 2006, 9(21): 1745-1748.
  169. Gao S, Bian Y, Wang YT. Normative investigation and analysis of pharmaceutical preparations instructions in Macao. Health Science Journal of Macao. 2006, 6(2): 114-116.
  170. Gao S, Bian Y, Wang YT. Normative investigation and analysis of pharmaceutical preparations labels in Macao. Health Science Journal of Macao. 2006, 6(1): 10-12.
  171. Zhao J, Li SP, Shi YR, Bian Y, Wang YT. The industrialization development strategy of TCM chemical reference substances. Research & Information on Traditional Chinese Medicine. 2005, 7(7): 36-38.
  172. Zhang GH, Li SP, Wan JB, Xia Q, Wang YT. Simultaneous determination of 9 compounds of saponins in PNS injections by RP-HPLC. Anhui Medical and Pharmaceutical Journal. 2005, 9(9): 664-665.
  173. Yu H, Jiang Y, Li P, Li SP, Wang YT. Study on analytical method for alkaloids in Bulbus Fritillariae Cirrhosae. China Journal of Chinese Meteria Medica. 2005, 30(8): 572-575.
  174. Yang FQ, Li SP, Chen Y, Liu QQ, Wang YT, Dong TX, Zhan HQ. The fingerprint of Ezhu by GC-MS. Acta Pharmaceutica Sinica. 2005, 40(11): 1013-1018.
  175. Yang FQ, Li SP, Chen Y, Liu QQ, Wang YT, Dong TX, Zhan HQ. Quantitative determination of curcumol, germacrone and curdione from Zedoray Rhizome by GC-MS. Chinese Journal of Pharmaceutical Analysis. 2005, 25(7): 827-830.
  176. Xiao H, Wang YT. The development trends of clinical pharmacy. Health Science Journal of Macao. 2005, 5(2): 113-115.
  177. Wan JB, Xu C, Li SP, Kong LY, Wang YT*. Studies on the pressurized solvent extraction of isoflavonoids from Pueraria Lobata. Chinese Journal of Analytical Chemistry. 2005, 33(10): 1435-1438. (IF=0.397)
  178. Wan JB, Li SP, Kong LY, Kan KW, Wang YT*. Advances in quality evaluation of Piper methysticum. Progress in Pharmcaceutical Sciences. 2005, 29(1): 19-22.
  179. Wan JB, Li CM, Li SP, Kong LY, Wang YT*. Analysis of saponins from Panax notoginseng using pressurized solvent extraction coupled with liquid chromatography-electrospray mass spectrometry. Journal of Chinese Medicinal Materials. 2005, 28(10): 885-890.
  180. Shi YR, Zhao J, Wang YT, Bian Y. Analysis and solution suggestions on the difficulties of protecting Chinese medicine patent. Research & Information on Traditional Chinese Medicine. 2005, 7(4): 37-40.
  181. Shi YR, Wang YT, Bian Y, Jiang B. The two cornerstones of the modernization of TCM – Standardization and intellectual property protection of TCM. China Pharmaceuticals. 2005, 14(4): 2-3.
  182. Shi YR, Wang YT, Bian Y. The necessity of combining standardization and intellectual property protection of traditional Chinese medicine. Chinese Journal of Practical Medicine. 2005, 5(9): 855-856.
  183. Qiu L, Zhao J, Song MX, Bian Y, Wang YT. Feasibility of the development of traditional Chinese medicine futures in China. Research & Information on Traditional Chinese Medicine. 2005, 7(7): 33-40.
  184. Qiu L, Lin J, Zhao J, Wang YT, Bian Y. Study on the application of Real Option Model on new drug R&D projects. Contemporary Finance & Economics. 2005, (11): 137-140.
  185. Qiu L, Bian Y, Wang YT, Lin J. Discussing the medical security for the migrant worker in town and urban. Health Economics Research. 2005, (08): 18-19.
  186. Qiu L, Bian Y, Wang YT, Lin J. Economic thinking on the sub-health medical services. Soft Science Health. 2005, 19(4): 277-279.
  187. Ni JY, Bian Y, Wang YT. Discussion on the development strategies of Chinese patent medicine in China. China Pharmaceutical Technology Exchange. 2005, 5(5): 33-35.
  188. Ni JY, Bian Y, Wang YT. Discussion on the differentiation strategies for expanding the international market of Chinese medicines. Research & Information on Traditional Chinese Medicine. 2005, 7(5): 31-34.
  189. Li XZ, Wang YT, Shi LW. Study on how China cosmetic admittance system should transmit to a registration and recording system. Detergent & Cosmetics. 2005, 28(8): 9-12.
  190. Hu YJ, Ge ZJ, Shao R, Bian Y, Wang YT. China pharmaceutical industry calls for an industry policy law. China Pharmaceuticals. 2005, 14(12): 2-3.
  191. Hu LF, Li SP, Wang YT. Advances on the research of targeted drug delivery system for traditional Chinese medicine. Chinese Journal of New Drugs. 2005, 14(12): 1387-1390.
  192. Gao S, Bian Y, Wang YT. Discussion on the internationalization of Chinese medicine from the aspect of Chinese medicine labels and instructions. Research & Information on Traditional Chinese Medicine. 2005, 7(9): 44-46.
  193. Gao JL, Yu ZL, Li SP, Wang YT*. Research advance on triterpenoids of Ganoderma lucidum. Edible Fungi of China. 2005, 24(4): 6-11.
  194. Yu H, Jian JR, Li P, Li SP, Wang YT*. Erythrocyte carrier – A novel drug delivery system. Journal of Chinese Clinical Medicine. 2004, 5(8): 3-6.
  195. Xia Q, Zhang P, Li SP, Wang YT. Research progress on the pharmacological activities of Danggui. Lishizhen Medicine and Materia Medica Research. 2004, 15(3): 164-166.
  196. Wang TJ, Li SP, Jian JR, Wang YT. Advances in the studies of anti-tumour activity of alkaloids in Radix Sophorae Flavescentis (Kushen). Chinese Journal of Experimental Medical Formulae. 2004, 10(4): 52-55.
  197. Wan JB, Li SP, Kan KW, Kong LY, Wang YT*. Analysis of saponins from Panax notoginseng using pressurized solvent extraction coupled with high performance thin layer chromatography. Chinese Journal of Natural Medicines. 2004, 2(4): 215-218.
  198. Shi LW, Zheng CY, Jiang B, Wang YT. Drug price policy and the development of pharmaceutical industry. Chinese Pharmaceutical Affairs. 2004, 18(5): 291-292.
  199. Shi LW, Hu B, Jiang B, Cao WZ, Wang YT. New drug innovation and registration in the USA. Chinese Pharmaceutical Affairs. 2004, 18(6): 352-353.
  200. Li XZ, Bian Y, Wang YT. How to realize the international standardization for traditional Chinese herbal cosmetics. Detergent & Cosmetics. 2004, 27(12): 556-558.
  201. Li P, Wan JB, Li SP, Wang YT*. Studies on the accelerated solvent extraction of Panax notoginseng saponins. Chinese Journal of Natural Medicines. 2004, 2(3): 157-161.
  202. Li P, Li SP, Gong YX, Wang YT. Simultaneous determination of ergosterol, nucleosides and their bases from natural and cultured Cordyceps by pressurized solvent extraction and high performance liquid chromatography. Acta Pharmaceutica Sinica. 2004, 39(11): 917-920.
  203. Li P, Li SP, Fu CM, Kan KW, Wang YT*. Pressurized solvent extraction in quality control of Chinese herb. China Journal of Chinese Meteria Medica. 2004, 29(8): 723-726.
  204. Hu YJ, Song RL, Shao R, Wang YT. Overview and development trends of foreign and domestic pharmaceutical laws and regulations. China Pharmacist. 2004, 7(11): 890-892.
  205. Hu YJ, Bian Y, Shao R, Wang YT. Comparison of foreign and domestic pharmaceutical industry policy. China Pharmaceuticals. 2004, 13(5): 9-10.
  206. Hu YJ, Bian Y, Shao R, Wang YT. The present situation, problems and countermeasures of the overall arrangement of China’s pharmaceutical industry. Science & Technology Industry of China. 2004, (6): 36-38.
  207. Hu YJ, Bian Y, Shao R, Wang YT. Study on the industrial organization of Chinese pharmaceutical industry. Soft Science. 2004, 18(6): 28-30.
  208. Shi LW, Gu J, Wang YT. Problems and challenges of regulating drug adverse reactions in the USA. Chinese Pharmaceutical Affairs. 2003, 17(8): 481-482.

 


Academic service

  • Advisory committee / Panel member
    - Executive Director and Deputy Secretary-General, World Federation of Chinese Medicine Societies
    - Vice President, Professional Committee of Pharmacology, World Federation of Chinese Medicine Societies
    - Vice President, Standardization Committee, World Federation of Chinese Medicine Societies
    - Secretary-General, International Society of Chinese Medicine
    - Senior consultant of the FP7 EU-China Consortium on Modernisation of Chinese medicine research (GP-TCM)
    - Executive Chair, Research Association of Senior Education of Chinese Medicine
    - Standing Committee Member, Chinese Pharmacological Society (CNPHAR)
    - Member, Expert Committee of National Drug Evaluation of China
    - Member, Expert Committee of Major Program of National Natural Science Foundation of China
    - Member, National Committee on Assessment of State Science and Technology Award
    - Member, National Committee on Assessment for the Secrecy of Science and Technology
    - Member, National Assessment Committee on Protective Chinese Medicine

 


Contact Details

Room 1050, 1F, N22
Institute of Chinese Medical Sciences 
University of Macau, Macao, China 
Telephone: (853) 8822 4691 
Fax: (853) 2884 1358
Email: YTWang@umac.mo


SECRETARY TO THE DIRECTOR

Chloe I-Man LAO (Ms) Room 1050, 1F, N22
Institute of Chinese Medical Sciences 
University of Macau, Macao, China
Telephone: (853) 8822 4691 
Fax: (853) 2884 1358
Email: IManLao@umac.mo